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BIBLIOGRAPHIC DESCRIPTION 
 
Chen, Rui 
 
Effects of bioflavonoids on cultured human retinal pigment 
epithelial cells 
 
University of Leipzig, Medical Faculty, Dissertation 
64 pages, 119 references, 20 figures, 8 tables. 
 
 
    The thesis describes the effects of various plant flavonoids (curcumin, 
epigallocatechin-3-gallate [EGCG], luteolin, apigenin, myricetin, quercetin, and cyanidin) 
on the physiological properties and viability of cultured human retinal pigment epithelial 
(RPE) cells. It is described that, with the exception of EGCG, all flavonoids tested decrease 
dose-dependently the RPE cell proliferation, migration, and secretion of VEGF. Luteolin, 
apigenin, myricetin, and quercetin decreased the viability of RPE cells at higher 
concentrations, by triggering cellular necrosis. Curcumin decreased the viability of RPE 
cells via induction of early necrosis and delayed apoptosis. The cytotoxic effect of curcumin 
involved activation of caspase-3 and calpain, intracellular calcium signaling, mitochondrial 
permeability, oxidative stress, and increased phosphorylation of p38 MAPK and decreased 
phosphorylation of Akt protein. Myricetin caused caspase-3 independent RPE cell necrosis 
mediated by free radical generation and activation of calpain and phospholipase A2. The 
myricetin- and quercetin-induced RPE cell necrosis was partially inhibited by necrostatin-1, 
a blocker of programmed necrosis. The author concludes that the intake of curcumin, 
luteolin, apigenin, myricetin, and quercetin as supplemental cancer therapy or in the 
treatment of retinal diseases should be accompanied by careful monitoring of the retinal 
function. Possible beneficial effects of EGCG and cyanidin in the treatment of retinal 
diseases should be examined in further investigations. 
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BIBLIOGRAFISCHE BESCHREIBUNG  
 
Chen, Rui 
 
Wirkung pflanzlicher Flavonoide auf kultivierte humane 
Pigmentepithelzellen 
 
Universität Leipzig, Medizinische Fakultät, Dissertation 
64 Seiten, 119 Literaturstellen, 20 Abbildungen, 8 Tabellen. 
 
 
    Die Arbeit beschreibt die Wirkungen verschiedener pflanzlicher Flavonoide (Curcumin, 
Epigallocatechin-3-gallat [EGCG], Luteolin, Apigenin, Myricetin, Quercetin und Cyanidin) 
auf die physiologischen Eigenschaften und die Lebensfähigkeit kultivierter humaner 
retinaler Pigmentepithel (RPE)-Zellen. Es wird gezeigt, dass - mit Ausnahme von EGCG - 
alle getesteten Flavonoide dosisabhängig die Proliferation und die Migration, sowie die 
Sekretion von VEGF inhibieren. Luteolin, Apigenin, Myricetin und Quercetin 
verschlechterten die Lebensfähigkeit der Zellen in höheren Konzentrationen durch 
Auslösung einer Zellnekrose. Curcumin induzierte sowohl Nekrose als auch Apoptose in 
RPE-Zellen. Der zytotoxische Effekt von Curcumin wurde durch Aktivierung der Caspase-3, 
von Calpainen, und einer intrazellulären Kalziumreaktion vermittelt, sowie durch eine 
erhöhte Permeabilität der Mitochondrienmembran, oxidativen Stress, Aktivierung der 
p38-MAPK und Inhibition der Phosphorylierung des Akt-Proteins. Myricetin induzierte eine 
Caspase-3-unabhängige Zellnekrose, die durch oxidativen Stress und eine Aktivierung von 
Calpainen und der Phospholipase-A2 vermittelt wurde. Die Myricetin- und  
Quercetin-induzierte Zellnekrose wurde teilweise durch Necrostatin-1, einem Blocker der 
programmierten Nekrose, inhibiert. Die Autorin schlussfolgert aus ihren Untersuchungen, 
dass die Aufnahme von Curcumin, Luteolin, Apigenin, Myricetin und Quercetin als 
Krebstherapie oder bei der Behandlung von Netzhauterkrankungen durch eine Überprüfung 
der Netzhautfunktion begleitet sein sollte. Mögliche therapeutische Effekte von EGCG und 
Cyanidin bei der Behandlung von Netzhauterkrankungen sollten in zukünftigen 
Untersuchungen bestätigt werden. 
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List of abbreviations 
Abbreviation Full name 
AMD Age-related macular degeneration 
BrdU 5-bromo-2'-deoxyuridine 
cDNA Complementary DNA 
CNV choroidal neovascularization 
DNA Deoxyribonucleic acid 
EDTA Ethylenediaminetetraacetic acid 
EGCG (-)-Epigallocatechin-3-gallate 
ELISA The enzyme-linked immunosorbent assay 
FBS Fetal Bovine Serum 
FGF Fibroblast growth factor 
mRNA Messenger RNA 
PDGF Platelet-derived growth factor 
PEDF Pigment epithelium-derived factor 
RNA Ribonucleic acid 
RPE Retinal pigment epithelialium 
rRNA Ribosomal RNA 
TNF tumor necrosis factor 
TRIS Tris-(hydroxymethyl)-aminoethane 
VEGF Vascular epithelial growth factor 
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1. Introduction 
1.1.  The retina 
The sensory retina, a highly specialized extension of the brain, is a thin (~0.25 mm thick in 
the human eye), multi-layered photosensitive tissue coating the inner back of the eyeball 
(Fig. 1). The inner part of the retina (which borders on the vitreous cavity) is the neural 
retina, which contains photoreceptors and neuronal cells. The outer part of the retina is 
constituted by the retinal pigment epithelium (RPE) which is a cellular monolayer lying on 
the Bruch's membrane, a multi-layer basement membrane. This membrane overlies the 
choriocapillaris that supplies the RPE and photoreceptors with oxygen and nutrients. The 
choriocapillaris is the inner part of the choroidea that finally borders on the sclera, the outer 
capsule of the eye. The interface between the neural retina and the RPE is the subretinal 
space; it contains a fluid compartment and the interphotoreceptor matrix. 
 
 
 
Fig. 1. Section through the back wall of the eye (right). (Source: Reichenbach and 
Bringmann, 2012). 
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1.2.  Age-related macular degeneration 
 
RPE cells play crucial roles in protecting the outer retina from photooxidative stress, in the 
digestion of shed photoreceptor outer segments which contain oxidized lipids and proteins, 
and in inhibition of retinal edema and neovascularization (Fig. 2) (Strauss, 2005). 
Dysfunction and degeneration of the RPE is crucially involved in the pathogenesis of 
age-related macular degeneration (AMD) (Roth et al., 2004; Nowak, 2006). AMD is the 
main blinding disease in the elderly in industrial countries (Van Leeuwen et al., 2003; Klein 
et al., 2007). The majority (~90%) of the patients suffer from the dry form of AMD that is 
characterized by geographic atrophy of the RPE followed by a degeneration of the neural 
retina. The remaining patients have the wet (exsudative) form of AMD, which is 
characterized by a subfoveal choroidal neovascularization (CNV; Fig. 3A, B). Here, new 
blood vessels grow across the Bruch's membrane below the RPE or across the damaged 
RPE into the subretinal space. The newly formed vessels have a dysfunctional blood-retinal 
barrier; the influx of serum results in the development of subretinal edema and a detachment 
of the RPE (Campochiaro, 2000). Subretinal edema and dysfunction of the RPE cause 
apoptotic/necrotic degeneration of photoreceptors and thus a progressive decrease in visual 
acuity (Miller, 2010). The subretinal CNV membranes are composed of vascular endothelial 
cells, RPE cells, Müller glial cells, macrophages, and leukocytes. 
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Fig. 2. Functional roles of the RPE. RPE cells absorb excess light, mediate the 
transepithelial transport of ions, glucose and other substrates, mediate the ion homeostasis, 
regenenerate photopigments, phagocytize shedded photoreceptor outer segment membranes, 
and secrete regulatory factors such as pigment epithelium-derived factor (PEDF) towards 
the neuroretina and vascular epithelial growth factor (VEGF) towards the choriocapillaris. 
MV, microvilli; OS, photoreceptor outer segments. (Source: Strauss, 2005).   
 
 
 
Fig. 3. Choroidal neovascularization. A. Artist’s rendition showing three-dimensional view 
of choroidal neovascularization breaking through Bruch’s membrane and growing partially 
beneath and par- tially above the retinal pigmented epithelium (RPE). The RPE proliferates 
and forms multiple layers that almost completely surround the margins of the choroidal 
neovascularization. B. A 10-µm frozen section of the mouse retina with laser-induced 
choroidal neovascularization stained with Griffonia simplicifo lia lectin, which results in the 
light gray staining in the subretinal space. The dark black staining results from pigment in 
the RPE and choroid. The retinal neurons are counterstained to show the photoreceptor 
nuclei, the inner nuclear layer, and the lightly stained retinal ganglion cells. (Source: 
Campochiaro, 2000).  
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 The development of CNV is assumed to be a response to the hypoxia of 
photoreceptors, which is caused by the accumulation of lipoproteins between the RPE and 
choroidea. Due to the light exposure, the high oxygen consumption and the presence of high 
polyunsaturated fatty acid levels, photoreceptors display a high level of lipid peroxidation  
(Kopitz et al., 2004). Peroxidized lipids cause alterations of the photoreceptor proteins 
(Hollyfield et al., 2008). One function of RPE cells is the phagocytosis and digestion of the 
tips of photoreceptor outer segments, which are shed, in a daily schedule (Fig. 2) (Strauss, 
2005). However, peroxidized photoreceptor lipids and proteins cannot be effectively 
degraded by RPE cells (Anderson et al., 2002; Krohne et al., 2010). This results in 
accumulation of lipofuscin within the RPE cells and of lipoprotein-containing drusen 
beneath the cells. Accumulated lipoproteins constitute a hydrophobic barrier, which disturbs 
the transport of oxygen and metabolic substrates to the photoreceptors. Hypoxia induces the 
production and release of angiogenic factors, which stimulate the growth of new vessels and 
the opening of the blood-retinal barrier. Simultaneously, these factors induce inflammation. 
The most important angiogenic factor is the vascular endothelial growth factor (VEGF) 
(D'Amore, 1994; Miller et al., 1994; Vinores et al., 1997). VEGF is mainly produced by 
RPE and Müller cells, as well as by invading macrophages (Ishibashi et al., 1997). Further 
angiogenic factors are the basic fibroblast growth factor, the platelet-derived growth factor 
(PDGF), and the tumor necrosis factor (TNF)-α (Soubrane et al., 1994; Perry et al., 1995; 
Mori et al., 2002; Schlingemann, 2004; Jo et al., 2006). However, the mechanisms how 
drusen stimulate the development of CNV is largely unclear. It is likely that inflammatory 
factors within the drusen, e.g., complement factors, which induce the expression of VEGF in 
RPE cells, play a pathogenic role. The crucial role of VEGF in the development of CNV is 
underlined by the fact that intravitreal injection of anti-VEGF antibodies or other agents 
which capture VEGF is an effective therapy of CNV in a large portion of patients with wet 
AMD (Campa and Harding, 2011; Chiang and Regillo, 2011). Anti-VEGF therapies 
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improve the visual acuity in approximately one third of patients with wet AMD. However, 
more than half of patients do not improve visual acuity after anti-VEGF therapy and about 
10% of patients do not respond to the treatment (Tranos et al., 2013). Therefore, it is 
required to develop novel therapeutic strategies, which inhibit further angiogenic signaling 
pathways (Miller, 2010). 
 
1.3.  Plant bioflavonoids as potential therapeutics 
 
Numerous studies carried out in the last years have shown that vegetable polyphenols (plant 
bioflavonoids) possess a wide range of activities in the prevention of common diseases 
including cancer, inflammation, infections, neovascularization, and neurodegenerative 
diseases (Hadi et al., 2000; Prasad et al., 2010; González-Gallego et al., 2010). Intake of 
bioflavonoids as dietary supplements or natural food is suggested to be helpful as 
supplemental therapy of cancer and chronic inflammation. Many dietary flavonoids have 
anti-inflammatory and anti-oxidant properties. For example, catechins of green tea, of which 
(-)-epigallocatechin-3-gallate (EGCG) is the most abundant, can inhibit tumorigenesis and 
angiogenesis in tumor tissues (Cao and Cao, 1999; Lambert and Elias, 2010). The natural 
phenolic compound curcumin (diferuloylmethane), the yellow pigment of turmeric and an 
ingredient in curry powders, has a long history of use in traditional Asian medicine for a 
wide variety of disorders. Curcumin has been shown to have anti-inflammatory, anti-oxidant, 
and anti-proliferative effects in various cell systems (Joe et al., 2004; Aggarwal and Sung, 
2009). In addition, curcumin has anti-viral effects, inhibits the proliferation of bacteria and 
fungi (Li et al., 1993; Kim et al., 2009, 2010; Rechtman et al., 2010), and induces 
immunosupression in subjects with renal transplants (Bharti et al., 2010). Curcumin is 
recognized as a promising anti-cancer drug and is believed to be helpful as concomitant 
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therapy of a variety of diseases associated with chronic inflammation and as adjuvant 
immunosuppressant (Aggarwal et al., 2003, 2006; Strimpakos and Sharma, 2008; Aggarwal 
and Sung, 2009; Mancuso and Barone, 2009; Epstein et al., 2010). Curcumin influences 
multiple intracellular signaling pathways and has both anti-oxidant and pro-oxidant effects 
in dependence on the concentration of the compound (Bhaumik et al., 1999; Hadi et al., 
2000; Aggarwal et al., 2003; Chen et al., 2005). It induces apoptosis of cancer cells by 
activation of procaspases and the release of cytochrome c from mitochondria (Anto et al., 
2002; Aggarwal et al., 2005; Gao et al., 2005). Both anti-oxidant and pro-oxidant activities 
were shown to be involved in the anti-cancer activity of curcumin (Bhaumik et al., 1999; 
Hadi et al., 2000; Chen et al., 2005). However, it is conceivable that cytotoxic effects of 
curcumin may also concern non-transformed cells. Indeed, it has been found that curcumin 
causes toxicity to non-transformed cells under some circumstances (Epstein et al., 2010; 
Marathe et al., 2009; Burgos-Morón et al., 2010). 
 Enhanced production of free oxygen and nitrogen radicals contributes to the 
pathogenesis of AMD (Beatty et al., 2000). Because bioflavonoids have anti-inflammatory 
and radical scavenging activities and suppress angiogenesis, vegetable polyphenols could 
have also potential benefits in inhibiting retinal diseases associated with oxidative stress, 
inflammation, and neovascularization. Indeed, EGCG was shown to protect the retina from 
ischemic damage, mainly via its anti-oxidative activity (Ueda et al., 1996; Chida et al., 
1999). Green tea, EGCG, and other flavonoids like luteolin, myricetin, and quercetin, were 
also shown to attenuate experimental retinal neovascularization, ischemic retinal injury, 
diabetic retinopathy, and light-induced photoreceptor apoptosis, respectively (Laabich et al., 
2007; Zhang et al., 2008; Costa et al., 2008; Peng et al., 2008; Park et al., 2012; Silva et al., 
2013). Curcumin was suggested to have potential benefits in inhibiting the development of 
diabetic retinopathy, age-related macular degeneration, and retinitis pigmentosa (Kowluru 
and Kanwar, 2007; Mandal et al., 2009; Vasireddy et al., 2011). Dietary curcumin reduced 
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oxidative changes and inhibited the elevations of interleukin-1β, TNFα, and VEGF in the 
retina of hyperglycemic rats (Kowluru and Kanwar, 2007; Mrudula et al., 2007; Gupta et al., 
2011). Dietary curcumin also inhibited the upregulation of inflammatory genes in a rat 
model of light-induced retinal degeneration, and protected retinal cells from oxidative cell 
death (Mandal et al., 2009). Curcumin also protected photoreceptors from degeneration in a 
transgenic rat model of retinitis pigmentosa (Vasireddy et al., 2011), prevented 
staurosporine-induced death of retinal ganglion and amacrine cells in the murine retina 
(Burugula et al., 2011), and inhibited neuronal apoptosis and microvessel degeneration in 
experimental ischemia-reperfusion injury of the retina (Wang et al., 2011).  
 The mechanisms of the protective activities of flavonoids in various diseases are not 
fully understood (Lambert and Elias, 2010). Many bioflavonoids including green tea 
catechins were shown to have anti-oxidant activity at low concentrations and pro-oxidant 
activity at high concentrations (Hadi et al., 2000; Galati et al., 2002; Lambert and Elias, 
2010). Both anti-oxidant and pro-oxidant effects were suggested to be implicated in the 
anti-inflammatory and anti-cancer activities of dietary flavonoids (Lambert and Elias, 2010). 
The pro-oxidant effect appears to be responsible for the induction of apoptosis in tumor cells 
and may also cause indirect anti-oxidant effects via induction of endogenous anti-oxidant 
systems in normal tissues that offer protection against oxidative stress (Lambert and Elias, 
2010). However, it has also been shown that excessive intake of vegetable polyphenols as 
dietary supplements or natural food may have adverse effects, e.g., by inhibition of 
prosurvival pathways and induction of apoptosis, as shown for curcumin in human retinal 
endothelial cells (Premanand et al., 2006). Curcumin and resveratrol (from red wine) were 
shown to reduce the viability of RPE cells by inducing apoptosis and necrosis (Alex et al., 
2010). The cytotoxicity of dietary flavonoids is helpful in the treatment of cancer, but may 
also induce death of non-transformed cells (Burgos-Morón et al., 2010).   
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1.4.  Aim of the study 
 
Elevated oxidative stress contributes to the pathogenesis of AMD (Beatty et al., 2000; Liang 
and Godley, 2003; Bailey et al., 2004). Anti-oxidant nutrients were shown to decrease the 
risk of the development of age-related macular degeneration (Mares-Perlman et al., 1996; 
Age-Related Eye Disease Study Research Group, 2001; Richer et al., 2004). It has been 
suggested that anti-oxidative plant bioflavonoids may have therapeutic effects in retinal 
diseases associated with inflammation and neovascularization. However, plant flavovoids 
may have also adverse effects resulting in the induction of apoptosis (Premanand et al., 2006; 
Burgos-Morón et al., 2010). Therefore, before plant flavonoids are clinically used in the 
treatment of retinal diseases such as AMD, it is required to determine whether these agents 
also have detrimental effects in RPE cells. Therefore, we examined whether various plant 
flavonoids have toxic effects in cultured human RPE cells. We also determined the effects 
of various plant flavonoids on the expression and secretion of VEGF, the main angiogenic 
factor implicated in the development of CNV (D'Amore, 1994). In addition, because 
proliferation and migration of RPE cells is involved in the formation of CNV membranes 
(Fig. 3A), we determined the effects of flavonoids on the proliferation and migration of RPE 
cells. In the first part of the study, we examined the effects of curcumin. In the second part 
of the study, we examined the effects of the following flavonoids: EGCG, luteolin (from 
parsley), apigenin (from celery and parsley), myricetin (from black tea, grapes, walnuts, 
etc.), quercetin (from bulbs), and cyanidin (from various plants such as red cabbage, 
blueberries, and strawberries). 
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2. Materials and methods 
2.1.  Materials 
2.1.1. Chemicals and reagents 
Tab. 1. Chemicals and reagents that were used in the experiments.  
 
Chemicals/Reagents Company 
0.2N phosphate buffer Zentralapotheke of the University of 
Leipzig 
5-Mercaptoethanol Carl Roth, Karlsruhe 
BCIP (5-Bromo-4-chloro-3-indolyl phospate 
p-toluidine salt) 
Carl Roth, Karlsruhe 
5x Reaction Buffer Thermo, USA 
6x DNA loading Dye  Fermentas, Sankt Leon 
Aceton J.T.Baker, USA 
Acrylamid-Bisacrylamid Solution (AA/BAA 
37,5:1) 
SERVA, Heidelberg 
Agarose Biozym, Hessisch Oldendorf 
Ammonium peroxydisulphate (APS) Carl Roth, Karlsruhe 
Apigenin Sigma, Deisenhofen 
Boric acid Carl Roth, Karlsruhe 
bromophenol blue Bio-Rad, München 
CoCl2 Sigma, Deisenhofen 
Curcumin Sigma, Deisenhofen 
Cyanidin Sigma, Deisenhofen 
DMF (Dimethylformamide) Sigma, Deisenhofen 
DMSO Sigma, Deisenhofen 
dNTP Mix, 10mM Thermo scientific, USA 
EDTA Bio-Rad, München 
EGCG Sigma, Deisenhofen 
Ethanol J.T.Baker, USA 
Ethidium bromide Bio-Rad, München 
Gelatin Sigma, Deisenhofen 
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Gene Ruler 100bp DNA ladder Fermentas, St-Leon-Rot 
Glycine Carl Roth, Karlsruhe 
HCl Merck, Darmstadt 
Hematoxylin Dr. K. Hollborn & Söhne, Leipzig 
HEPES Carl Roth, Karlsruhe 
IQ SYBR Green Supermix  Bio-Rad, Munich 
Karnofsky’ reagent Dr. K. Hollborn & Söhne, Leipzig 
Luteolin Sigma, Deisenhofen 
Myricetin Sigma, Deisenhofen 
Methanol Carl Roth, Karlsruhe 
NaCl Carl Roth, Karlsruhe 
Oligo(dT)18 Primer Thermo, USA 
PageRuler Prestained Protein Ladder Thermo, USA 
Phosphatase Inhibitor Cocktail Sigma, Deisenhofen 
PMSF (Phenylmethylsulfonylfluorid) Carl Roth, Karlsruhe 
Protein Assay Reagent 5* concentrate Bio-Rad, München 
Protein Assay Standard II Bio-Rad, München 
Protease Inhibitor Cocktail Sigma, Deisenhofen 
Quercetin Sigma, Deisenhofen 
RevertAid Reverse Transcriptase Thermo, USA 
RiboLock RNase Inhibitor Thermo, USA 
Roti-Block Carl Roth, Karlsruhe 
SDS (Sodium-Dodecyl-Sulfat) Carl Roth, Karlsruhe 
TEMED Carl Roth, Karlsruhe 
Tris Base Carl Roth, Karlsruhe 
Trypan blue solution 0.4% Sigma, Deisenhofen 
Tween-20 Roche, Mannheim 
 
Tab. 2. Primer pairs that were used in PCR experiments. s, sense. as, anti-sense. 
 
Gene and  
Accession 
Primer sequence (5’→3’) 
Amplicon 
(bp) 
ACTB s   ATGGCCACGGCTGCTTCCAGC  237 
NM_001101 as  CATGGTGGTGCCGCCAGACAG  
VEGFA s   
CCTGGTGGACATCTTCCAGGAGTA 
407; 347; 275 
NM_001025370 as  CTCACCGCCTCGG TTGTCACA  
BFGF  s   AGAGCGACCCTCACATCAAG 234 
NM_002006 as  ACTGCCCAGTTCGTTTCAGT  
 18 
HGF s   GGCTGGGGCTACACTGGATTG 179 
NM_000601 as  CCACCATAATCCCCCTCACAT  
CASP3  s   ACTGGAAAACCCAAACTTTTCAT 245 
NM_004346 as  ATAAATTCAAGCTTGTCGGCATA  
CASP8 s   CATCCAGTCACTTTGCCAGA 128 
NM_03356.3 as  GCATCTGTTTCCCCATGTTT  
BAX s   CAAGAAGCTGAGCGAGTGTCT 152 
NM_0043234 as  AGTTGAAGTTGCCGTCAGAAA  
SMAC s   
ACTTGGGAAAATGAATTCAGAGG 
163 
NM_138929.3 as  A TTTGAT T C GCTTCT CT  
2.1.2. Antibodies 
Tab. 3. Antibodies that were used in the experiments.  
 
Antibody Company Solution 
Anti BrdU-POD antibody  1:200 
Anti-human Akt antibody (rabbit polyclonal) Cell signaling 1:1000 
Anti-human p42/44 MAPK antibody (rabbit polyclonal) Cell signaling 1:1000 
Anti-human GAPDH antibody, (rabbit polyclonal) Cell signaling 1:2000 
Goat anti-Rabbit IgG AP- linked antibody  Cell signaling 1:2000 
Anti-human SAPK/JNK antibody (rabbit polyclonal), New England 
Biolabs 
1:1000 
Neutralizing rabbit anti-human TNFα antibody Abcam 1:1000 
Anti-human p38 MAPK antibody (rabbit polyclonal), Cell signaling 1:1000 
Anti-human phospho-Akt antibody, (rabbit polyclonal) Cell signaling 1:750 
Anti-human phospho- p42/44 MAPK antibody (rabbit 
polyclonal) 
Cell signaling 1:1000 
Anti-human phospho-p38 MAPKinase Antibody, (rabbit 
polyclonal) 
Cell signaling 1:750 
Anti-human phosphorylated SAPK/JNK antibody (rabbit 
polyclonal) 
New England 
Biolabs 
1:1000 
2.1.3. Cytokines 
PDGF-BB (R&D Systems, Minneapolis, MN) was used in distinct experiments at 
concentrations described in the Results section.  
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2.1.4. Inhibitory agents 
Tab. 4. Inhibitory agents that were used in the experiments. 
 
Name Target Company 
2'-amino-3'-methoxyflavone 
(PD98059) 
MEK Calbiochem, Bad 
Soden, Germany 
3,4-Dihydro-5-[4-(1-piperidinyl)b
utoxy]-1(2H)-isoquinoline (DPQ) 
PARP-1 Sigma-Aldrich, USA 
3-(4-Iodophenyl)-2-mercapto-(Z)-
2-propenoic acid (PD150606) 
calpain Calbiochem, Bad 
Soden, Germany 
4-bromophenacyl bromide Phospholipase A2 Sigma-Aldrich, USA  
anthra(1-9-cd)pyrazol-6(2H)-one 
(SP600125) 
JNK Calbiochem, Bad 
Soden, Germany 
Ac-DEVD-CHO Caspase-3 Enzo Life Science,  
Lörrach, Germany 
Ac-IETD-CHO Caspase-8 Enzo Life Science,  
Lörrach, Germany 
Cyclosporin A Mitochondrial 
permeability transition 
Calbiochem, Bad 
Soden, Germany 
Dithiothreitol (DTT) Reducing agent Carl Roth, Karlsruhe 
Inactive Necrostatin Inactive control of 
necroptosis 
Calbiochem, Bad 
Soden, Germany 
Indomethacin Prostaglandins Sigma, Deisenhofen 
Necrostatin-1 necroptosis Calbiochem, Bad 
Soden, Germany 
Perindopril ACE Sigma, Deisenhofen 
Pinacidil Potassium channels Sigma, Deisenhofen 
2.1.5. Kits 
Tab. 5. Kits that were used in the experiments. 
 
Kits Company 
Cellular DNA Fragmentation ELISA Roche, Mannheim 
Cell proliferation ELISA BrdU Kit (colorimetric) Roche, Mannheim 
InviTrap Spin Universal RNA Mini Kit Stratec,Berlin 
Mammalian Cell Lysis Kit Sigma, Deisenhofen 
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RNase-Free Dnase set Qiagen, Hilden 
RNeasy Mini Kit Qiagen, Hilden 
Quantikine® ELISA human VEGF Immunoassay  R&D GmbH, Wiesbaden 
Quantikine® ELISA Human FGF basic Immunoassay  R&D GmbH, Wiesbaden 
2.1.6. Consumables 
Tab. 6. Cell culture medium and additives for RPE cell culturing and dissociation that were 
used in the experiments. 
 
Name Company 
F10 Nutrition Mix+GlutaMAX Invitrogen, Karlsruhe 
Fetal Bovine Serum (FBS) Invitrogen, Karlsruhe 
PBS (sterile) Invitrogen, Karlsruhe 
Penicillin/Streptomycin (×100) Invitrogen, Karlsruhe 
0.5% Trypsin-EDTA  Invitrogen, Karlsruhe 
 
Tab. 7. Consumables that were used for cell culturing and different assays.  
 
Name Company 
6-well cell culture Plate [657160] Greiner Bio-one, Frickenhausen 
12-well cell culture Plate [665180] Greiner Bio-one, Frickenhausen 
24-well cell culture Plate Becton Dickinson, Heidelberg 
96-well cell culture Plate [655180] Greiner Bio-one, Frickenhausen 
Blotting paper Th.Geyer,Germany 
Bags Carl Roth, Karlsruhe 
Cell culture flasks 75 cm² [658170] Greiner Bio-one, Frickenhausen 
Eppendorf tubes 0.5 ml; 1.5 ml Sarstedt, Nümbrecht 
Latex Gloves Hartmann, Heidenheim  
polyethylene terephthalate filter inserts 
(diameter 6.4 mm, pore size 8 µm; 
Becton Dickinson, Heidelberg 
PVDF-Membran , Immobilon-P Carl Roth, Karlsruhe 
QPCR Seal Film PEQLAB,Erlangen 
Standard 96 well PCR plates PEQLAB,Erlangen 
Tubes 15, 50 ml Greiner Bio-one, Frickenhausen  
2.1.7. Devices 
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Tab. 8. Devices that were used for different assays.  
 
Devices Manufacture 
Bag sealer Hawo, Obrigheim 
Balance, BP2100 Sartorius, USA 
Centrifuge GS-15R Beckman Coulter, Krefeld 
Centrifuge Microfuge R Beckman Coulter, Krefeld 
CO2 -Incubator (STERI CULT 200) Thermo Scientific, USA 
Electrophoresis apparatus for Agarose gel (mini 
Sub-Cell GT)  
Bio-Rad, Munich 
Electrophoresis Power supply (PowerPacHC) Bio-Rad, Munich 
ELISA Reader (Spectra Max 250) Molecular Devices, USA 
Fine balance Sartorius Göttingen Gel documentation 
system (ChemiDoc XRS) 
Bio-Rad, Munich 
Haemocytometer Brand, Wertheim 
Heating block Eppendorf, Hamburg 
Inverse tandard-Microscope, Axiovert 25 Carl Zeiss, Jena 
Laminar flow clean bench Nuaire, USA 
Microwave  Siemens, Munich 
Mini Protean II Tetra Cell BioRad, München,  
Multi-Chanel Pipette (8 Channels, 20-200 µl) Eppendorf, Hamburg 
MyiQ single color Real-time PCR detection System 
(with MyiQ Software) 
Bio-Rad, Munich 
PH-Meter Mettler Toledo, Giessen 
Pipettor Eppendorf, Hamburg 
Semi-dry transfer unit, TE70X Hoefer, USA 
Shaker Heidolph,Schwabach 
Spectrophotometer, NANO DROP1000 PEQLAB,Erlangen 
Table centrifuge  Labnet,USA 
Thermal cycler,PTC 200 MJ Research,USA 
Thermal shaker Eppendorf, Hamburg 
Vortexer, REAX2000 Heidolph, Schwabach 
Water bath GFL, Burgwedel 
2.2.  Methods 
2.2.1. RPE cell cultures 
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The use of human material was approved by the Ethics Committee of the University of 
Leipzig (Ethikvotum AZ 038/13-ff) and was performed according to the Declaration of 
Helsinki. RPE cells were isolated and primarily cultured from eyes of human donors without 
apparent eye diseases within 48 h of death. RPE cells were isolated as following: After 
removing the anterior segment, vitreous and neural retina, the eye cups were washed with 
PBS, and the RPE cells were mechanically harvested. The cells were dissociated by 
digestion with 0.05% trypsin and 0.02% EDTA at 37°C for 5 min. Then, the cells were 
washed with medium plus 10% FBS. After centrifugation, the supernatant was removed, 
and the cell pellets were resuspended with complete F-10 medium with 10% FBS and 
cultured in culture flasks in 95% air/5% CO2 at 37°C. Cells of passage 3 to 5 were used for 
the experiments. 
2.2.2. Cell proliferation 
Cell proliferation requires DNA synthesis; therefore, determination of the DNA synthesis 
rate can be used as marker of cell proliferation. The Cell Proliferation ELISA BrdU 
(colorimetric) Kit (Roche, Mannheim, Germany) was used to determine the incorporation of 
BrdU into the newly synthesized DNA. The cells were seeded at 3000 cells/well in 100 µL 
F-10 medium with 10% FBS in 96-well culture plates. The cells were incubated at 37°C, 
95 % air/5 % CO2 until 90% of confluence was reached. After washing the cells with PBS, 
the cells were serum-starved by culturing the cells in 100 µL medium without FBS at 37°C 
for 5-6 h. Then the cells were stimulated with test substances at different concentrations in 
medium containing 0.5% FBS for 24 h. Thereafter, the cells were labeled with BrdU 
labeling solution (100 µM) 10 µL/ well by incubating at 37°C, 95 % air/5 % CO2 for 4 h. 
Then, the labeling medium was removed and the cells were fixed by adding 70 µL/well 
FixDenat at room temperature for 45 min. After removing the fixation solution, medium 
was added and the culture plates were stored in the refrigerator overnight. After removing 
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the medium, 50 µL/well anti-BrdU-POD working solution was added for 2 h at room 
temperature. Then, the plates were washed with PBS and incubated with substrate solution 
(TMB) 100 µL/well at room temperature for 10 - 30 min. The incubation was stopped by 
applying 25 µl/well stop solution (1 M H2SO4). The absorbance of the samples was 
measured with an ELISA reader at 450 nm. 
 The following test substances were used: curcumin (0.1, 1, 10, 50, 75 µM), EGCG 
(1, 5, 10, 50, 100 µM), luteolin (0.1, 1, 10, 50 µM), apigenin (1, 5, 10, 100 µM), myricetin:1, 
10, 20, 50, 100 µM), quercetin (1, 10, 50 µM), and cyanidin: 0.1, 1, 10, 100, 200 µM). The 
following vehicles were used: 0.2% ethanol, 0.2% acetone, 0.1% DMSO, and 0.2% 
methanol. As positive control, PDGF (10 ng/ ml) was used. The anti-BrdU-POD antibody 
solution (1:200) was used in the following medium: Ca2+- and Mg2+-containing HBSS (500 
ml), FBS (50 ml), Pen/Strep (5 ml), and HEPES buffer (1 M; 5 ml).  
2.2.3. Cell viability 
The cells were seeded at 8x104 per well in 2 mL F-10 medium with 10% FBS in 6-well 
plates. The cells were incubated at 37°C, 95 % air/5 % CO2 until 90% of confluence was 
reached. After culturing the cells in serum-free medium for 16 h at 37°C, the cells were 
stimulated with test substances at different concentrations in medium containing 0.5% FBS 
for 24 h. After washing the cells with PBS, the cells were harvested from each well of the 
6-well plates by trypsinization with 0.5 ml 0.5% trypsin-EDTA (37°C, 2~5 min). Thereafter, 
2 mL medium with 10% FBS were added into the wells to prevent further cell damage. The 
cell suspension were transferred into 50 mL tubes, and then centrifuged at 1500 rpm for 6 
min. After centrifugation, the cell supernatants were removed by suction and the cell pellets 
were re-suspended with 50 µl medium with 10% FBS. 20 µl of cell suspension and 20 µl of 
0.4% trypan blue were mixed and incubated at room temperature for 3 min. 20 µl of trypan 
blue-cell mixture was applied to a hemacytometer and then examined under a phase-contrast 
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microscope. The numbers of stained (nonviable) and non-stained (viable) cells were counted. 
The percentage of viable cells was calculated. 
 The following test substances were used: curcumin (1, 10, 100 µM), EGCG (1, 10, 
100 µM), luteolin (1, 10, 100 µM), apigenin (1, 10, 100 µM), myricetin (1, 10, 100 µM), 
quercetin (1, 10, 100 µM), and cyanidin (0.1, 1, 10, 100 µM).  
2.2.4. Migration 
Chemotaxis was determined with a modified Boyden chamber assay. Polyethylene 
terephthalate filters (insert diameter, 6.4 mm; pore size, 8 µm; Becton Dickinson, 
Heidelberg, Germany) coated with fibronectin (50µg/ml) and gelatin (0.5 mg/ml) were used 
for cell seeding. 50.000 cells were seeded per insert in 100 µL medium with 0.5% FBS. The 
inserts were placed in 24 well plates and incubated at 37°C, 95 % air/5 % CO2 overnight. 
The test substances (see 2.2.3; dissolved in 800 µL medium containing 0.5% FBS) were 
added into the lower chamber. 
 After incubation of the cells with the test substances at 37°C, 95 % air/5 % CO2 for 6 
h, the media from the inserts and wells were removed, and the cells were fixed with ½ 
strength Karnofsky`s reagent at room temperature for 45 min. After fixation, the membranes 
of the inserts were carefully scraped with a tip and cleaned with a cotton swab to remove the 
non-migrated cells. The inserts were stained with hematoxylin at room temperature for 45 
min. Then, the inserts were rinsed with water and the migrated cells were counted with a 
phase-contrast microscope using a counting net. 
2.2.5. RNA isolation 
The total RNA was isolated from RPE cell lysates by using the RNeasy Mini Kit (Qiagen, 
Hilden, Germany). The DNA digestion was carried out with the RNase-Free DNAse Set 
(Qiagen, Hilden, Germany). The cells were seeded at 80000/well into 6-well plates and 
 25 
cultured in a medium containing 10% FBS at 37°C, 95 % air/5 % CO2. When 90% 
confluence was reached, the cells were serum starved overnight. Then, the cells were 
stimulated with the test substances in the medium without FBS for 2 or 6 h. After washing 
with ice-cold PBS, the cells were disrupted with 350 µL buffer RLT (containing 1 ml buffer 
RLT and 10 µl mercaptoethanol) per well. The cell lysates were collected into 0.5 ml 
Eppendorf tubes and stored at -70°C.  
 The cell lysates were mixed with 350 µL 70% ethanol and transferred into the 
RNeasy spin column placed in a 2-ml collection tube. Then, the lysates were centrifuged for 
20 s at 15.000 rpm, and the supernatants were discarded. 350 µl of buffer RW1 was applied 
to the RNeasy spin column, and the column membrane was centrifuged for 20 s at 15.000 
rpm to wash the spin column membrane. The supernatants were discarded and the spin 
columns were placed in a new 2 ml collection tube. 80 µl of DNase I incubation mix was 
added directly onto the RNeasy spin column membrane, and the membrane was was 
incubated at room temperature for 15 min. 500 µl of buffer was added into the RNeasy spin 
column, and the column membrane was centrifuged for 20 s at 15.000 rpm. The 
supernatants were discarded and 500 µl of buffer was added into the RNeasy spin column, 
and the column membrane was centrifuged for 2 min at 15.000 rpm. After discarding the 
supernatants, the RNeasy spin column was placed in a new 1.5 ml collection tube. 40µl of 
RNase-free water was added directly to spin column membrane, and the membrane was 
centrifuged for 1 min at 15.000 rpm to elute the RNA. 
2.2.6. RNA quantification 
The purity of RNA samples was assessed by determining the A260/A280 ratio with the 
NanoDrop ND-1000 d (peQLab, Erlangen, Germany). The pedestal of the device was 
cleaned with ethanol. Then, 1µL of water was loaded. After water was wiped from both 
upper and lower pedestals, a drop of sample (1µL) was loaded and the optical density was 
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measured at 260 nm (maximum for nucleic acids) and 280 nm (maximum for proteins). An 
A260/A280 ratio between 1.9 and 2.1 indicates a sufficient quality of the RNA samples. 
Representative results of one analysis of diverse RNA samples using the Nanodrop device 
are shown in Figure 4. 
 
 
 
Fig. 4. Analysis of RNA samples with the Nanodrop device. The graph shows representative 
results of one measurement of diverse RNA samples. The inset shows a representative 
image of a RNA electrophoresis using 2 µg of total RNA. 
2.2.7. RNA electrophoresis 
Denaturing agarose gel electrophoresis checked the integrity of RNA samples. The 
respective ribosomal RNAs (28S and 18S rRNA) should appear as clear bands with a ratio 
of 28S/18S RNA of approximately 2:1 (Figure 4, inset).  The following agents were used 
to perform the electrophoresis:   
RNAse free DEPC- water (1 mL DEPC in 1 L water; mixed very intensively, incubated 
overnight, and then sterilized); 
0.5 M EDTA (37.224 g EDTA in 200 ml sterile water; the pH was adjusted with NaOH to 
8.0); 
3M Na-acetate (49.218 g sodium acetate in 200 ml sterile water); 
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10x MOPS buffer (41.8 g MOPS, 16.6 ml 3M sodium acetate, and 20.0 ml 0.5 M EDTA  
in 1 L sterile water; pH 7.0); and  
RNA sample loading buffer (720 µl formamide, 160 µl 10x MOPS, and 260 µl 37% 
formaldehyde in 200 µl sterile water and 80 µl glycerol; 80 µl bromophenol blue/xylene 
cyanol [saturated solution] were added).  
50 mL of 1% gel solution was prepared. 0.5 g of agrose was dissolved in 42.5 mL 
DEPC-water with 5 mL 10x MOPS buffer. After heating with microwave, 2.5 mL of 
formaldehyde and 10 µl of ethidium bromide (100 µg/ml) were added. After the solution 
was cooled down, the gel was poured into the tray with a comb to form wells. The gel was 
assembled in the tank, 1x MOPS (10xMOPS diluted with DEPC- water) was used as 
running buffer to cover the gel, and the comb was removed. The RNA was prepared before 
the application by incubating at 65°C for 5 min. At least 2 µg of RNA was used for 
electrophoresis. The gel was running by implying constant voltage at 80 V for 60 min until 
the dye (bromophenol blue) was migrated at least 3-4 cm into the gel.  
2.2.8. cDNA synthesis 
Total RNA was used as template for cDNA synthesis. The reaction was performed in 
500-µL PCR tubes that contained 0.5 µL of oligo(dT)18 primer and 1.5 µL of nuclease-free 
water. 2 µL of this mixture and 10.7 µL of the RNA sample were done into a PCR tube. 
After mixing by vortexing and centrifugation, the samples were incubated at 65°C for 5 min. 
Then, 7.2 µl of the following substance mix were added to each sample: 5x reaction buffer 
(4 µL), RibolockTM RNase Inhibitor (20 µg/µl; 0.5 µL), d NTP Mix (10 mM; 2 µL), and 
RevertAid™ M-MuLV Reverse Transcriptase (200 U/µl; 0.8 µL). After mixing by vortex 
and centrifugation, the samples were incubated at 42°C for 60 min, and the reaction was 
stopped by heating the samples to 70°C for 10 min. 
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2.2.9. Real-time RT-PCR 
Real-time RT-PCR is a method to determine quantitative changes in the cellular mRNA 
levels. The PCR reaction was performed in 96-well plates containing 15 µl of the reaction 
solution constituted of 7.5 µl of SM (super mix), 0.375 µl of the sense primer (10µM, final 
concentration 0.25 µM), 0.375 µl of the anti-sense primer (10µM, final concentration 0.25 
µM), 5.75µl of nuclease-free water, and 1µl of cDNA. The plates were covered with sealing 
film and centrifuged at 1500 rpm. The following PCR program was used: 
 
Step    Time (min:sec)    TPCR(°C) 
1      3:00     95
 enzyme activation 
------------------------------------------------------------------------------------ 
      0:30     95
 denaturation 
2  45 repeats    0:20     58 
 amplification 
      0:45     72
 elongation and quantification 
------------------------------------------------------------------------------------ 
3      1:00     95  
4      1:00     55  
------------------------------------------------------------------------------------ 
5 81 repeat    0:10     55 to 95 
melt curve analysis 
(0.5°C steps) 
------------------------------------------------------------------------------------ 
6      ever     4  
 
The experiments were carried out in triplicate. The IQ5 multicolor real-time PCR detection 
system was used to record the fluorescence change after each cycle, and Ct values of the 
target mRNA and β-actin mRNA were measured. The relative level of mRNA was 
calculated by MyIQ Software according to the formulas:  
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ΔCtsample = Cttarget gene – Ctβ-actin 
ΔCtreference= Cttarget gene – Ctβ-actin 
ΔΔCt = ΔCtsample – ΔCtreference 
Relative mRNA value of target genes =2- ΔΔCt 
2.2.10. Agarose gel electrophoresis  
The PCR products were checked by agarose gel electrophoresis. Charging separated the 
DNA fragments. The DNA was detected by ethidiumbromide under ultraviolet light. If a 
DNA band of specific molecular weight was showed up, the mRNA was included in the 
sample, and the associated gene was regarded as being expressed. The gel solution (1.7%) 
was prepared by using 1 g of agarose powder and 60 ml of TBE buffer that contained (per L) 
10.8 g of Tris base (89 mM), 5.5 g of boric acid (89 mM), and 4 ml of 0.5 M EDTA, pH 8.0. 
The solution was heated in a microwave device to melt agarose. Then, the gel solution was 
cooled down until it could be holded in hand, then it was poured into the tray. 10 µL of 
ethidiumbromide (0.1 mg/ml) was added into the gel and mixed. Then, a comb was inserted 
into the casting tray to form slots for the samples. The gel was solidified at room 
temperature for 20 min. 
 The gel-casting tray was placed in the electrophoresis chamber. Then, the chamber 
was fully filled with the electrophoresis buffer 1×TBE solution, and the comb was removed 
carefully. 2-3 µL of 6× loading buffer (DNA loading dye) was mixed with each sample, and 
20 µL of the sample or 10 µL of the marker (Gene Ruler 100bp DNA ladder) was applied to 
the gel slots. Thereafter, the gel was running by implying a constant voltage at 80 V for 
25-30 min. The DNA Samples migrated from the negative to the positive pole. The samples 
were visualized with ChemiDoc XRS (BioRad München). 
2.2.11. DNA fragmentation ELISA 
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The DNA fragmentations ELISA assay was performed to determine whether RPE cell 
undergoes apoptosis or necrosis after administration of the test substances. The cells were 
seeded into 96-well culture plates at 4000 cells/well in 100 µL of culture medium 
supplemented with 10% FBS and incubated at 37°C, 95 % air/5 % CO2. When the cultures 
reached 90% confluence, the cells were loaded with BrdU labeling solution (100 µM; 10 
µL/well) for 16 h. After washing with PBS, the cells were stimulated with the test 
substances dissolved in medium containing 0.5% FBS for 6 and 24 h, respectively. Then, 
the supernatants and cell lysates were collected separately and were used as samples for the 
DNA fragmentation ELISA.  
 The ELISA was carried out as following: the 96-well, flat-bottom plates were coated 
with 100 µL of an anti-DNA antibody solution at 4 °C overnight. Then, the non-specific 
binding sites were blocked with 200 µL of incubation solution at room temperature for 30 
min. After washing, 100µL of the sample were transferred to each well and incubated at 
room temperature for 30 min. After washing, the DNA was fixed and denatured by 
microwave irradiation. Then, 100 µL of anti-POD conjugate solution were added into each 
well and incubated at room temperature for 90 min. At the end of incubation, the wells were 
washed and incubated with 100-µL substrate solutions in dark until the color development 
was sufficient. Then, 25 µL of stop solution was applied. The absorbance of the samples 
was measured with an ELISA reader at 450 nm within 5 min. 
 The following test substances were used: curcumin (1, 10, 50, 100 µM), EGCG (1, 
10, 50 µM), luteolin (0.1, 1, 10, 50 µM), apigenin (0.01, 0.1, 1, 10, 50 µM), myricetin (1, 10, 
20, 50, 100 µM), quercetin (0.1, 1, 10, 50 µM), and cyanidin (0.1, 1, 10, 100, 200 µM). The 
following vehicles were used: ethanol (0.2%), acetone (0.2%), DMSO (0.1%), and methanol 
(0.2%). The effects of the test substances were determined in the presence and absence of 
PDGF (10 ng/ml) and CoCl2 (150 µM), respectively. 
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2.2.12. ELISA 
The levels of secreted proteins in the culture supernatants (200 µl for VEGF-A; 100 µl for 
bFGF) were determined with ELISA. The ELISA kit (R&D Systems) contained each buffer, 
reagent, and solution used. The cells were seeded at 3000/well in 100 µL of F-10 medium 
supplemented with 10% FBS in 96-well plates. The cells were incubated at 37°C, 95% 
air/5% CO2 until 90% of confluence was reached. After serum starvation for 16 h, the cells 
were stimulated with the test substances in a medium that contained 0.5% FBS for 6 h. The 
culture supernatants were collected at the end of the incubation period and were used as 
samples for the ELISA assay.  
 The VEGF standard stock solution was produced with 2000 pg/mL of RD5K. The 
dilution series was produced with standard stock solutions ranging from 2000 to 31.25 pg/mL. 
The ELISA assay was performed in 96-well plates. At first, 50 µl of the assay diluent RD1W 
was added into each well. Then, 200 µl of standard, control, or sample solutions were mixed 
with the diluent RD1W. The plates were covered with sealing film and incubated for 2 h at 
room temperature. After washing with washing buffer (400 µl) for three times, the wells were 
filled with 200 µl of antibody conjugate and incubated for 2 h at room temperature. Then, the 
wells were washed with washing buffer (400 µl) for another three times. 200 µl of substrate 
solution was added into each well under protection from light. The color reaction was stopped 
with 50 µl of stop solution. The optical density of the samples was measured with an ELISA 
reader at 450 nm. Plotting the absorbance for each standard on the y-axis against the 
concentration on the x-axis and then drawing a best-fit curve by lining each point on the 
graph constructed a standard curve. Plotting the logarithm of the VEGF concentrations versus 
the logarithm of the optical density linearized the data, and the best-fit line was determined by 
regression analysis. 
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2.2.13. Western blot analysis 
The cells were seeded at 1 x 105 cells per well in 6 well plates in 1.5 ml complete medium, 
and were allowed to growth up to a confluency of ~90 %. After growth arrest for 16 h, the 
cells were treated with test substances for 15 min. Then, the medium was removed, the cells 
were washed twice with prechilled phosphate-buffered saline (pH 7.4; Invitrogen, Paisley, 
UK), and the monolayer was scraped into 150 µl lysis buffer (Mammalian Cell Lysis-1 Kit; 
Sigma). The total cell lysates were centrifuged at 10,000 x g for 10 min, and the 
supernatants were analyzed by immunoblots. Equal amounts of protein (30 µg) were 
separated by 10% SDS-polyacrylamide gel electrophoresis. Immunoblots were probed with 
primary and secondary antibodies, and immunoreactive bands were visualized using 
5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium. 
2.2.14. Statistics 
For each test, at least three independent experiments were carried out in triplicate using cells 
from different donors. Data are expressed as mean ± SEM. Statistical analysis was made by 
using the Prism program (Graphpad Software, San Diego, CA). Significance was 
determined by One-way ANOVA followed by Bonferroni's multiple comparison test, and 
was accepted at P<0.05. 
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3 Results 
3.1. Effects of curcumin 
 
3.1.1. Gene expression and secretion of VEGF 
 
Because VEGF is a key player in choroidal neovascularization (Witmer et al., 2003), and 
RPE cells are one source of VEGF in the retina (Blaauwgeers et al., 1999), we determined 
whether curcumin, a flavonoid of turmeric and an ingredient in curry powders, may regulate 
the gene expression and secretion of VEGF from RPE cells. The expression of the VEGF 
gene was determined with real-time PCR after incubation of the cells with curcumin for 2 
and 6 h. The results show that curcumin had no effect on the cellular level of VEGF mRNA 
after 2 h of stimulation (Fig. 5A). However, after 6 h of stimulation, curcumin significantly 
(P<0.05) decreased the gene expression of VEGF in RPE cells compared to the untreated 
control (Fig. 5A). The secretion of VEGF from RPE cells was determined with ELISA by 
measuring the VEGF protein level in the cultured media. We measured the VEGF protein 
level in the cultured media in the absence and presence of PDGF. PDGF is a well-known 
angiogenic factor of the retina and stimulates the secretion of VEGF from RPE cells 
(Hollborn et al., 2006). In addition, we measured the secretion of VEGF from RPE cells in 
the presence of CoCl2, a known hypoxia mimetic (An et al., 1998). Both PDGF and 
chemical hypoxia induced by addition of CoCl2 stimulated the secretion of VEGF from RPE 
cells (Fig. 5B). Curcumin inhibited dose-dependently the PDGF- and CoCl2-induced 
stimulation of the VEGF secretion from RPE cells (Fig. 5B). Curcumin at 50 and 100 µM 
fully abrogated the secretion of VEGF under all conditions tested (Fig. 5B).  
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Fig. 5. Curcumin inhibits the gene expression and secretion of VEGF from RPE cells. A. 
Concentration-dependent effect of curcumin on the gene expression of VEGF-A. The 
mRNA level was determined by real-time RT-PCR after stimulation of the cells with 
curcumin for 2 and 6 h, respectively. B. Concentration-dependent effect of curcumin on the 
secretion of VEGF from RPE cells. The effects were determined in the absence (control) 
and presence of PDGF (10 ng/ml) and CoCl2 (150 µM), respectively, for 6 h. ELISA 
determined the level of VEGF-A165 in the cultured media. The concentration of curcumin 
(in µM) is given in the bars. The vehicle control was made with ethanol (0.2%). Data are 
means ± SEM of 3-6 independent experiments carried out in triplicate using cells from 
different donors. Significant difference vs. untreated control: *P<0.05; **P<0.01. 
Significant difference vs. PDGF and CoCl2, respectively: ●P<0.05; ●●P<0.01. 
 
3.1.2. Proliferation and migration of RPE cells  
 
In wet AMD, RPE cells proliferate and migrate and contribute to the formation of subretinal 
neovascular membranes. We determined the effects of curcumin on the proliferation and 
migration of RPE in the absence and presence of PDGF, a known mitogen and motogen of 
RPE cells (Hollborn et al., 2006). We found that curcumin at concentrations above 10 µM 
decreased dose-dependently the proliferation rate of RPE cells under both control and 
PDGF-stimulated conditions (Fig. 6A). The inhibitory effect of curcumin on cellular 
proliferation was found after 24 h (Fig. 6A) and 96 h (Fig. 6B) of stimulation. Curcumin at 
concentrations between 0.1 and 10 µM did not alter the chemotaxis of RPE cells under both 
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control and PDGF-stimulated conditions (Fig. 6C). Curcumin at 50 µM increased slightly, 
but significantly (P<0.05) the chemotaxis under control conditions (Fig. 6C). 
 
 
 
 
Fig. 6. Concentration-dependent effects of curcumin on the proliferation (A, B) and 
chemotaxis (C) of RPE cells. The rate of BrdU incorporation was measured after a 24- (A) 
and 96-h (B) incubation with the agents, respectively. The concentration of curcumin (in 
µM) is given in the bars. The effects were determined in the absence (control) and presence 
of PDGF (10 ng/ml). The vehicle control was made with ethanol (0.2%). Data are means ± 
SEM of 4-8 independent experiments carried out in triplicate using cells from different 
donors, and are expressed in percent of untreated control (100%). Significant difference vs. 
untreated control: *P<0.05; **P<0.01; ***P<0.001. Significant difference vs. PDGF control: 
●P<0.05; ●●P<0.01.  
 
3.1.3. Cell viability  
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We found that curcumin at concentrations above 10 µM decreased the proliferation of RPE 
cells (Fig. 6A, B). To determine whether this effect was caused by a decrease in the viability 
of the cells, we stained the cells with trypan blue and counted the living and dead cells. As 
shown in Figure 7A, curcumin decreased slightly the number of viable cells at 
concentrations between 1 and 50 µM. At higher concentrations (75 and 100 µM), curcumin 
strongly decreased the viability of the cells; almost no viable cells were found after the 
treatment of the cultures with curcumin at 100 µM (Fig. 7A). We compared the effect of 
curcumin on the cell viability with the effect of triamcinolone acetonide, an 
anti-inflammatory steroid clinically used in the treatment of inflammatory and ischemic 
retinopathies associated with edema (Fraser-Bell et al., 2008).  Though triamcinolone also 
decreased slightly the viability of the cells at higher concentrations, this effect was not 
significant (Fig. 7B). 
  
 
 
Fig. 7. Effects of curcumin (A) and triamcinolone acetonide (B) on the viability in RPE 
cells. The numbers of viable and dead cells were calculated after incubation with test 
substances after 24 hours from culture medium. Data are means ± SEM of 5-7 independent 
experiments carried out in triplicate using cells from different donors, and are expressed in 
percent of untreated control (100%). Significant difference vs. control: *P<0.05; **P<0.01. 
 
3.1.4. Induction of apoptosis/necrosis 
 37 
 
By measurement of the internucleosomal DNA fragmentation rate in the cultured media and 
cell lysates, we determined whether the curcumin-induced decrease in RPE cell viability 
was mediated by inducing apoptosis and/or necrosis. An increased level of BrdU-labeled 
DNA fragments in the cell-free culture supernatants reflects cellular necrosis, while an 
increased level of BrdU-labeled DNA fragments in the cell lysates reflects apoptosis of the 
cells. Curcumin at higher concentrations (50 and 100 µM) induced a significant (P<0.05) 
increase in the DNA fragmentation rate in the cultured media. This effect was found at both 
6 (Fig. 8A) and 24 h (Fig. 8B) after addition of curcumin to the culture media. An increase 
in the DNA fragmentation rate in the cell lysates was observed with curcumin at 100 µM 
after 6 h (Fig. 8A), and with curcumin at 10 and 50 µM after 24 h of stimulation (Fig. 8B). 
The data suggest that curcumin induces early necrosis and delayed apoptosis of RPE cells. 
In contrast to curcumin, triamcinolone acetonide up to 100 µM did not induce DNA 
fragmentation in RPE cells (not shown). 
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Fig. 8. Concentration- and time-dependent effect of curcumin on the rate of 
internucleosomal DNA fragmentation of RPE cells. The rate of DNA fragmentation was 
determined in the cell-free culture supernatants (reflecting cellular necrosis) and 
cytoplasmic lysates of the cells (reflecting apoptosis) after 6 (A) and 24 h (B) of cell 
culturing. The concentration of curcumin (in µM) is given in the bars. The vehicle control 
was made with ethanol (0.2%). Data are means ± SEM of 4-8 independent experiments 
carried out in triplicate using cells from different donors, and are expressed in percent of 
untreated control (100%). Significant difference vs. untreated control: *P<0.05; **P<0.01. 
 
3.1.5. Mechanisms of curcumin-induced RPE cell death 
 
To determine the mechanisms of the cytotoxic effect of curcumin, we tested various 
inhibitory agents. As shown in Figure 9, the inhibitor of the effector caspase-3, the 
tetrapeptide Ac-DEVD-CHO, reduced in part the curcumin-induced DNA fragmentation 
measured in the cultured media. The lack of effect of the caspase-3 inhibitor to completely 
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block curcumin-induced DNA fragmentation may indicate the contribution of 
caspase-independent apoptotic and necrotic death pathways to the cytotoxic effect of the 
compound. An additional mechanism that may contribute to curcumin-induced cytotoxicity 
is the activation of the calcium-sensitive cysteine protease calpain. The calpain inhibitor 
PD150606 (which prevents the binding of calcium to calpain and does not significantly 
inhibit cathepsins and caspases [Wang et al., 1996.]) fully inhibited the curcumin-induced 
DNA fragmentation and decreased significantly (P<0.05) the DNA fragmentation rate 
measured under control conditions (Fig. 9). The inhibitory effect of the cell-permeable 
calcium chelator BAPTA-AM (Fig. 9) supports the assumption that intracellular calcium 
signaling is involved in mediating the cytotoxic effect of curcumin. The data suggest that 
both caspase-dependent and -independent mechanisms mediate curcumin-induced RPE cell 
death. Overproduction of reactive oxygen species was associated with activation of the 
mitochondrial apoptotic pathway (Galluzzi et al., 2009).. As shown in Figure 9, the 
curcumin-induced DNA fragmentation measured in the cultured media was fully prevented 
in the presence of the cell-permeable dithiol-reducing agent dithiothreitol. One consequence 
of oxidative stress is activation of mitochondrial permeability transition which leads to 
mitochondrial dysfunction, energy failure, and enhanced free radical production. To 
determine whether mitochondrial membrane permeabilization is implicated in mediating the 
cytotoxic effect of curcumin, we tested the inhibitor of permeability transition, cyclosporin 
A (Crompton et al., 1988). As shown in Figure 9, cyclosporin A inhibited the 
curcumin-induced DNA fragmentation, but had no effect under control conditions. On the 
other hand, the curcumin-induced DNA fragmentation was not inhibited by a caspase-8 
inhibitor, the tetrapeptide Ac-IETD-CHO (Fig. 9), as well as by a neutralizing anti-TNFa 
antibody (Fig. 9), suggesting that the cytotoxic effect of curcumin does not involve 
activation of extrinsic apoptotic pathways. 
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Fig. 9. Mechanisms of curcumin-induced RPE cell apoptosis/necrosis. The rate of DNA 
fragmentation in the cultured media was determined after a 6-h stimulation of the cultures 
with curcumin (50 µM). The curcumin-induced DNA fragmentation was inhibited in the 
presence of the following agents: the caspase-3 inhibitor Ac-DEVD-CHO (DEVD; 100 µM), 
the calpain inhibitor PD150606 (PD; 100 µM), the cell-permeable calcium chelator 
BAPTA-AM (100 µM), the reducing agent dithiothreitol (DTT; 3 mM), and cyclosporin A 
(CsA; 1 µM), respectively. The curcumin-induced DNA fragmentation was not inhibited by 
the caspase-8 inhibitor Ac-IETD-CHO (IETD; 100 µM) and a neutralizing anti-TNFa 
antibody (20 µg/ml), respectively. Data are means ± SEM of 3-5 independent experiments 
carried out in triplicate using cells from different donors. Significant difference vs. untreated 
control: *P<0.05. Significant difference vs. curcumin control: ●P<0.05.  
 
3.1.6. Gene expression of proapoptotic proteins 
 
Inhibition of caspase-3 activation partially prevented the cytotoxic effect of curcumin (Fig. 
9). Thus, we determined whether curcumin induces (in addition to activation of caspase-3) 
also alterations in the gene expression of caspase-3. As shown in Figure 10A, curcumin at 
50 µM induced an early downregulation (after 2 and 6 h of stimulation) and a delayed 
upregulation of caspase-3 (after 24 h of stimulation). A similar regulation was found in the 
gene expression of the proapoptotic protein Smac that binds to inhibitor 
of apoptosis proteins and deactivates them. As shown in Figure 10B, curcumin at 50 µM 
induced an early downregulation (after 2 h of stimulation) and a delayed upregulation of 
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Smac (after 24 h of stimulation). On the other hand, curcumin (up to 50 µM) did not alter 
the gene expression of caspase-8 and Bax (not shown).  
 
 
 
Fig. 10. Effects of curcumin on the gene expression of caspase-3 (A) and Smac (B). The 
mRNA levels were determined by real-time RT-PCR after stimulation of the cells with 
curcumin for 2, 6, and 24 h, respectively. The concentrations of curcumin (in µM) are given 
in the bars. The vehicle control was made with ethanol (Eth; 0.2%). Data are means ± SEM 
of 4 independent experiments carried out in triplicate using cells from different donors. 
Significant difference vs. untreated control: *P<0.05. 
 
3.1.7. Activation of intracellular signal transduction molecules 
 
We used Western blot analysis to determine whether curcumin activates key molecules of 
intracellular signal transduction cascades. We found that curcumin (up to 100 µM; 15 min) 
did not alter the phosphorylation levels of extracellular signal-regulated kinases 1 and 2 
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(ERK1/2) and stress-activated protein kinase (SAPK)/c-Jun N-terminal kinase (JNK) in 
RPE cells (data not shown). However, curcumin induced dose-dependently phosphorylation 
of p38 mitogen-activated protein kinase (MAPK) protein (Fig. 11A). The curcumin-induced 
phosphorylation of p38 MAPK was inhibited by the selective inhibitor of p38 MAPK 
activation, SB203580 (Fig. 11B). In addition, curcumin induced a dose-dependent decrease 
in the phosphorylation level of protein kinase B (Akt) in RPE cells (Fig. 11C). 
 
 
 
Fig. 11. Curcumin induces phosphorylation of p38 MAPK and decreases phosphorylation of 
Akt in RPE cells. A. Dose-dependence of the curcumin effect on the phosphorylation level 
of p38 MAPK. As control, PDGF (10 ng/ml) was tested. B. The inhibitor of p38 MAPK 
activation, SB203580 (SB; 10 µM), decreased the curcumin-induced phosphorylation of p38 
MAPK. Curcumin was tested at 50 and 100 µM. C. Dose-dependence of the curcumin effect 
on the phosphorylation level of Akt. The cultures were stimulated with the agents for 15 min. 
The amounts of total proteins are shown above; the amounts of phosphorylated proteins are 
shown below. Similar results were obtained in 3 independent experiments using cells from 
different donors. 
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3.2. Effects of EGCG, luteolin, apigenin, myricetin, 
quercetin, and cyanidin 
3.2.1. Secretion of VEGF 
 
In order to determine whether bioflavonoids modulate the secretion of VEGF protein from 
RPE cells, we determined the level of VEGF-A165 in the cultured media with ELISA. The 
release of VEGF was examined under control conditions and after stimulation of the cells 
with PDGF and CoCl2-induced chemical hypoxia, respectively. As shown in Figure 12A, 
the major catechin of green tea, EGCG, did not alter the secretion of VEGF from RPE cells 
under control and PDGF-stimulated conditions when tested at concentrations between 1 and 
50 µM. However, EGCG induced a dose-dependent decrease in the secretion of VEGF 
induced by chemical hypoxia. All other bioflavonoids tested, i.e., luteolin (Fig. 12B), 
apigenin (Fig. 12C), myricetin (Fig. 12D), quercetin (Fig. 12E), and cyanidin (Fig. 12F), 
induced dose-dependent decreases in the secretion of VEGF from RPE cells under all 
conditions tested.  
 Myricetin induced a strong decrease in the secretion of VEGF protein from RPE 
cells (Fig. 12D). In order to determine whether the compound also alters the expression of 
the VEGFA gene, we carried out real-time RT-PCR. As shown in Figure 13A, myricetin 
induced a significant (P<0.05) decrease in the VEGFA expression at 10 µM, but a strong 
increase in VEGFA expression at 100 µM. Because the myricetin-induced increase in the 
gene expression of VEGF was reduced in the presence of an inhibitor of programmed 
necrosis, necrostatin-1 (Fig. 13B), it is suggested that high concentrations of myricetin 
induces cell stress which is characterized by (among others) increased gene expression of 
 44 
VEGF.  
 
 
 
Fig. 12. Dose-dependent effects of EGCG (A), luteolin (B), apigenin (C), myricetin (D), 
quercetin (E), and cyanidin (F) on the secretion of VEGF from RPE cells. The effects were 
determined in the absence (control) and presence of PDGF (10 ng/ml) and CoCl2 (150 µM), 
respectively, for 6 h. ELISA determined the level of VEGF-A165 in the cultured media. The 
concentrations of the test substances (in µM) are given in the bars. The vehicle controls 
were made with acetone (Ac; 0.1%), dimethylsulfoxide (DMSO; 0.1%), and methanol 
(MeOH; 0.2%), respectively. Data are means ± SEM of 3-6 independent experiments 
carried out in triplicate using cells from different donors, and are expressed in percent of 
untreated control (100%). Significant difference vs. untreated control: *P<0.05. Significant 
difference vs. PDGF and CoCl2 control, respectively: ●P<0.05. 
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Fig. 13. Effect of myricetin on the expression of the VEGFA gene. mRNA levels were 
determined by real-time RT-PCR after stimulation of the cells with myricetin for 2 and 6 h, 
respectively. A. Dose-dependency of the myricetin effect. The concentration of myricetin 
(in µM) is given in the bars. B. The stimulatory effect of myricetin (100 µM) on the gene 
expression of VEGF is decreased in the presence of the inhibitor of programmed necrosis, 
necrostatin-1 (Nec-1; 30 µM), but not in the presence of inactive necrostatin-1 (Nec-1i; 30 
µM). Vehicle controls were made with methanol (0.2%) and dimethylsulfoxide (DMSO; 
0.1%), respectively. Data are means ± SEM of 3-6 independent experiments carried out in 
triplicate using cells from different donors. Significant difference vs. untreated control: 
*P<0.05. Significant difference vs. myricetin: ●P<0.05. 
 
3.2.2. Proliferation and chemotaxis of RPE cells 
 
In order to determine whether bioflavonoids alter physiological characteristics of RPE cells, 
we measured the proliferation and chemotaxis of cultured cells in the absence and presence 
of PDGF. As shown in Figure 14A, EGCG as the major green tea catechin did not 
significantly alter the proliferation rate of RPE cells under control and PDGF-stimulated 
conditions. Similarly, EGCG had no effect on the chemotaxis of RPE cells, under both 
control and PDGF-stimulated conditions (Fig. 15A). All other bioflavonoids tested, i.e., 
luteolin, apigenin, myricetin, quercetin, and cyanidin, induced dose-dependent decreases of 
 46 
the proliferation rate under control and PDGF-stimulated conditions (Fig. 14B-F). Whereas 
the flavonoids (with the exception of EGCG) decreased dose-dependently the 
PDGF-induced chemotaxis of RPE cells (Fig. 15B-F), the chemotaxis under non-stimulated 
control conditions were differently regulated by different flavonoids. While apigenin and 
myricetin decreased the migration of the cells at the highest concentrations tested (Fig. 15C, 
D), luteolin and quercetin induced increased chemotaxis of RPE cells under control 
conditions (Fig. 15B, E), and cyanidin had no effect (Fig. 15F).  
 
 
 
 
Fig. 14. Dose-dependent effects of EGCG (A), luteolin (B), apigenin (C), myricetin (D), 
quercetin (E), and cyanidin (F) on the proliferation of RPE cells. The effects were 
determined in the absence (control) and presence of PDGF (10 ng/ml). The rate of BrdU 
incorporation was measured after 24-h incubation with the agents. The concentrations of the 
test substances (in µM) are given in the bars. The vehicle controls were made with acetone 
(Ac; 0.2%), dimethylsulfoxide (DMSO; 0.1%), and methanol (MeOH; 0.2%), respectively. 
Data are means ± SEM of 3-10 independent experiments using cells from different donors, 
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and are expressed in percent of untreated control (100%). Significant difference vs. 
untreated control: *P<0.05. Significant difference vs. PDGF control: ●P<0.05. 
 
 
 
 
Fig. 15. Dose-dependent effects of EGCG (A), luteolin (B), apigenin (C), myricetin (D), 
quercetin (E), and cyanidin (F) on the chemotaxis of RPE cells. The effects were 
determined in the absence (control) and presence of PDGF (10 ng/ml). The concentrations 
of the test substances (in µM) are given in the bars. The vehicle controls were made with 
acetone (Ac; 0.2%), dimethylsulfoxide (DMSO; 0.1%), and methanol (MeOH; 0.2%), 
respectively. Data are means ± SEM of 3-5 independent experiments using cells from 
different donors, and are expressed in percent of untreated control (100%). Significant 
difference vs. untreated control: *P<0.05. Significant difference vs. PDGF control: 
●P<0.05. 
 
3.2.3. Cell viability  
 
To determine whether the inhibitory effects of the flavonoids on the secretion of VEGF and 
the proliferation and chemotaxis of RPE cells involve a toxic effect on the cells, we 
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determined the cell viability by staining with trypan blue and counting the living and dead 
cells. Whereas EGCG (Fig. 16A) and cyanidin (Fig. 16F) up to a concentration of 100 µM 
did not significantly decrease the viability of the cells, luteolin (Fig. 16B), apigenin (Fig. 
16C), myricetin (Fig. 16D), and quercetin (Fig. 16E) induced significant (P<0.05) decreases 
in the cell viability at the higher concentrations tested. The data may suggest that toxic 
effects of the compounds at least at higher concentrations, mediate the effects of different 
flavonoids on the secretion of VEGF and the proliferation and chemotaxis of RPE cells. On 
the other hand, cyanidin decreased the secretion of VEGF (Fig. 17A) without a significant 
reduction in the cell viability (Fig. 17B). 
 
 
 
 
 
Fig. 16. Dose-dependent effects of EGCG (A), luteolin (B), apigenin (C), myricetin (D), 
quercetin (E), and cyanidin (F) on the viability of RPE cells. The cells were stimulated with 
test substances for 24 h. Data are means ± SEM of 3-7 independent experiments using cells 
from different donors. Significant difference vs. control: *P<0.05.  
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Fig. 17. Cyanidin decreases the secretion of VEGF (A) without a significant reduction in the 
cell viability (B). The level of VEGF-A165 in the cultured media (measured by ELISA) and 
the cell viability (measured by trypan blue exclusion) were determined by using the same 
cultures. The cells were stimulated with cyanidin for 6 h. The concentrations of cyanidin (in 
µM) are given in the bars. Data are means ± SEM of 5-7 independent experiments using 
cells from different donors. Significant difference vs. control: *P<0.05. 
 
3.2.4. Induction of apoptosis/necrosis  
 
By measurement of the internucleosomal DNA fragmentation rate in the cultured media and 
cell lysates, we determined whether the decrease in RPE cell viability induced by various 
flavonoids was mediated by induction of apoptosis and/or necrosis. Triton X-100 (1%) was 
used as positive control. As previously described (Hollborn et al., 2010), Triton induced an 
increase in the DNA fragmentation rate in the RPE cell lysate after 6 and 24 h of stimulation, 
while the DNA fragmentation rate in the cultured media remained unchanged (Fig. 18A-F). 
The data suggest that Triton evoked apoptosis but not necrosis of RPE cells. The green tea 
catechin EGCG did not induce apoptosis or necrosis of RPE cells at both time periods 
investigated when tested at concentrations between 10 and 100 µM (Fig. 18A). Luteolin (at 
50 µM) induced significant (P<0.05) increases in the DNA fragmentation rates in the cell 
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lysates and in the cultured media after 24 h of exposure (Fig. 18B), suggesting that it 
induced apoptosis and necrosis of RPE cells. Apigenin (at 100 µM) induced necrosis but not 
apoptosis of RPE cells (Fig. 18C). Myricetin did not induce apoptosis of RPE cells; however, 
it dose-dependently induced strong necrosis of the cells (Fig. 18D). Similarly, quercetin 
induced dose-dependently necrosis of RPE cells, whereas it did not induced apoptosis (Fig. 
18E). Cyanidin did not induce apoptosis but decreased the rate of cellular necrosis after 6 h 
of exposure (Fig. 18F). 
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Fig. 18. Dose-dependent effects of EGCG (A), luteolin (B), apigenin (C), myricetin (D), 
quercetin (E), and cyanidin (F) on the rate of DNA fragmentation of RPE cells. The rate of 
DNA fragmentation was determined in the cell lysates (to determine the level of cellular 
apoptosis) and culture supernatants (to determine the level of cellular necrosis) after 6 h (left 
side) and 24 h of cell culturing (right side). Triton X-100 (1%) was used as positive control. 
The vehicle controls were made with acetone (Ac; 0.2%), dimethylsulfoxide (DMSO; 0.2%), 
and methanol (Me; 0.4%), respectively. The concentrations of the test substances (in µM) 
are given in the bars. Data are means ± SEM of 3-6 independent experiments using cells 
from different donors, and are expressed in percent of untreated control (100%). Significant 
difference vs. untreated control: *P<0.05. 
 
3.2.5. Mechanisms of myricetin-induced RPE cell death  
 
Myricetin was found to induce severe necrosis of RPE cells (Fig. 18D). In order to 
determine the molecular mechanisms of myricetin-induced cytotoxicity, we evaluated the 
rate of DNA fragmentation in the cultured media in the presence of different caspase 
inhibitors. As shown in Figure 19A and B, the selective inhibitor of the effector caspase-3, 
DEVD, did not alter the rate of RPE cell necrosis induced by myricetin. The inhibitor of 
caspase-8, IETD, inhibited in part the myricetin-induced RPE cell necrosis after 6 h (Fig. 
19A), but not after 24 h of stimulation (Fig. 19B).   
The lack of an effect of the caspase-3 inhibitor may suggest that caspase 3-independent 
necrotic death pathways mediate the myricetin-induced cytotoxicity. An important activator 
of the caspase-independent cell death is the mitochondrial flavoprotein apoptosis-induced 
factor, which mediates chromatin condensation and DNA-fragmentation when translocated 
to the nucleus (Hong et al., 2004). The release of the apoptosis-induced factor from the 
mitochondria can be triggered by different mechanisms, including activation of 
poly(ADP-ribose) polymerase-1 (PARP-1). To determine whether activation of this nuclear 
enzyme participates in myricetin-induced RPE cell death, we used the selective PARP-1 
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inhibitor DPQ. DPQ did not prevent RPE cell necrosis induced by myricetin (Fig. 19A, B). 
Concomitant inhibition of PARP-1 and caspase-3 using DPQ plus DEVD did also not block 
myricetin-induced RPE cell death (not shown). Similarly, the inhibitor of the NADPH 
oxidase pathway and the uncoupling protein-2/mitochondrial pathway, perindopril, and the 
inhibitor of mitochondrial permeability transition, cyclosporin A, displayed no effects (Fig. 
19A, B). In addition, the mitochondrial KATP channel opener pinacidil had no effect (Fig. 
19A, B). The data suggest that activation of the mitochondrial apoptotic pathway is not 
involved in mediating the cytotoxic effect of myricetin.  
 
 
 
Fig. 19. Mechanisms of myricetin-induced RPE cell necrosis. The rate of DNA 
fragmentation in the cultured media was determined after stimulation of the cells with 
myricetin for 6 h (A) and 24 h (B), respectively. The following agents were tested in the 
absence (control) and presence of myricetin (200 µM): the caspase-3 and -8 specific 
inhibitors DEVD (100 µM) and IETD (100 µM), the PARP-1 inhibitor DPQ (30 µM), the 
inhibitor of the NADPH oxidase pathway and the uncoupling protein-2/mitochondrial 
pathway, perindopril (4 µM), the inhibitor of the mitochondrial permeability transition 
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cyclosporin A (CsA; 1 µM), the mitochondrial KATP channel opener pinacidil (10 µM), the 
calpain inhibitor PD150606 (100 µM), the reducing agent dithiothreitol (DTT; 3 mM), the 
inhibitor of phospholipase A2 4-bromophenacyl bromide (Bromo; 300 µM), the 
cyclooxygenase inhibitor indomethacin (Indo; 10 µM), the MEK inhibitor, PD98059 (20 
µM), and the JNK inhibitor, SP600125 (10 µM). Data are means ± SEM of 3-6 independent 
experiments using cells from different donors, and are expressed in percent of untreated 
control (100%). Significant difference vs. untreated control: *P<0.05. Significant difference 
vs. myricetin control: ●P<0.05. 
 
Another mechanism that could contribute to the myricetin-induced cytotoxicity is activation 
of the cysteine protease calpain. Pretreatment of RPE cells with the calpain inhibitor 
PD150606 fully abrogated the RPE cell necrosis induced by myricetin (Fig. 19A, B). The 
data suggest that calpain activation is involved in mediating the toxic effect of myricetin. 
Activation of apoptotic pathways (Galluzzi et al., 2009) and the excitotoxic death of 
oligodendrocytes (Liu et al., 2002) were shown to depend on the generation of reactive 
oxygen species. Preincubation of the cells with the cell-permeable dithiol-reducing agent 
dithiothreitol significantly (P<0.05) reduced the rate of RPE cell necrosis induced by 
myricetin (Fig. 19A, B). The data suggest that generation of free oxygen radicals contributes 
to the myricetin-induced cytotoxicity. We found also that the inhibitor of phospholipase A2, 
4-bromophenacyl bromides, reduced the cytotoxic effect of myricetin (Fig. 19A, B). On the 
other hand, the cyclooxygenase inhibitor indomethacin had no effect (Fig. 19A, B). 
Furthermore, inhibition of ERK1/2 activation with the specific MAPK kinase (MEK) 
antagonist PD98059 did not suppress the myricetin-induced DNA fragmentation (Fig. 19A, 
B). Inhibition of c-Jun NH2-terminal kinase (JNK) activation by SP600125 reduced slightly 
the DNA fragmentation rate after 6 h (Fig. 19A), but not after 24 h of myricetin stimulation 
(Fig. 19B).  
 In order to determine whether the myricetin-induced cytotoxicity is mediated by 
programmed necrosis, we tested the inhibitor of necroptosis, necrostatin-1 (Degterev et al., 
2005). As shown in Figure 20A, necrostatin-1 decreased significantly (P<0.05) the 
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myricetin-induced increase in the DNA fragmentation rate of the cultured media. On the 
other hand, the inactive derivative of necrostatin-1 (Degterev et al., 2005) had no effect (Fig. 
20A). We found also that the quercetin-induced increase in the DNA fragmentation rate of 
the cultured media is largely inhibited by necrostatin-1 (Fig. 20B). The data suggest that the 
myricetin-induced RPE cell necrosis is mainly mediated by activation of death pathways, 
which involve the generation of free oxygen radicals, and the activation of calpain and 
phospholipase A2, as well as activation of caspase-8 and JNK in the early phase of cell death. 
The myricetin-induced cytotoxicity is in part mediated by the induction of programmed 
necrosis. 
 
 
 
Fig. 20. Effect of the inhibitor of programmed necrosis, necrostatin-1 (Nec-1; 30 µM), on 
the DNA fragmentation rate in the cultured media of RPE cells. The cells were cultured for 
6 and 24 h in the presence of myricetin (200 µM; A) and quercetin (200 µM; B), 
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respectively. As negative control, inactive necrostatin-1 (Nec-1i; 30 µM) was tested. The 
vehicle control was made with dimethylsulfoxide (DMSO; 0.2%). Data are means ± SEM of 
3-7 independent experiments using cells from different donors, and are expressed in percent 
of untreated control (100%). Significant difference vs. untreated control: *P<0.05. 
Significant difference vs. quercetin and myricetin control, respectively: ●P<0.05. 
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4. Discussion  
In the first part of the present study, we determined whether curcumin alters physiological 
properties of RPE cells, which are characteristic for the development of AMD. In the second 
part, the effects of various other plant flavonoids (EGCG, luteolin, apigenin, myricetin, 
quercetin, and cyanidin) were examined. The results suggest that most bioflavonoids 
investigated have effects that may protect from the development and progression of AMD 
(e.g., inhibition of VEGF expression and of RPE cell proliferation), but that many 
flavonoids also have cytotoxic effects on RPE cells and induce cellular necrosis and 
apoptosis, respectively, at relatively low concentrations. Two compounds, EGCG and 
cyanidin, were found to have little effects on the cell viability and thus are suggested to be 
candidates for further examination as possible therapeutic agents in retinal diseases. 
 
4.1. Effects of curcumin in RPE cells 
 
The clinical interest in curcumin was motivated by data obtained in in-vitro and in-vivo 
studies that showed that curcumin induces proliferation arrest and apoptotic and necrotic 
death in a variety of tumor cells (Aggarwal et al., 2003, 2006; Strimpakos and Sharma, 
2008). Curcumin is also suggested to be helpful as concomitant therapy of diseases 
associated with chronic inflammation, and may be used as adjuvant immunosuppressant 
(Aggarwal and Sung, 2009; Mancuso and Barone, 2009; Epstein et al., 2010). Based upon 
data obtained in animal models of retinopathies and cultured retinal cells, it has been 
suggested that curcumin may also have potential benefits in inhibiting the development and 
progression of various blinding retinal disorders including AMD (Mandal et al., 2009). It 
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has been shown that curcumin increases the survival of retinal cells under various 
pathological in-vivo and in-vitro conditions including animal models of diabetic retinopathy, 
light-induced retinal degeneration, retinitis pigmentosa, and ischemia-reperfusion injury of 
the retina (Kowluru and Kanwar, 2007; Mandal et al., 2009; Vasireddy et al., 2011; Mrudula 
et al., 2007; Gupta et al., 2011; Wang et al., 2011). However, it was also shown that 
curcumin induces apoptosis in human retinal endothelial cells (Premanand et al., 2006) and 
decreases the viability of RPE cells (Alex et al., 2010). In the present study, we show that 
curcumin has toxic effects on human RPE cells. It induces early necrosis and delayed 
apoptosis in RPE cells which are mediated by caspase-dependent and -independent 
mechanisms, via intrinsic and mitochondrial apoptotic pathways. In addition, curcumin 
alters the expression and secretion of angiogenic cytokines in RPE cells. The cytotoxic 
effects of curcumin were observed at doses described to be effective in the treatment of 
tumor cells. Curcumin was shown to inhibit the proliferation and to induce death of cancer 
cells at concentrations between 5 and 50 µM, after incubation for several hours 
(Burgos-Morón et al., 2010; Puliyappadamba et al., 2010; Saha et al., 2010; Singh and 
Singh, 2011; Mudduluru et al., 2011). Anti-viral effects were found at much higher 
concentrations of curcumin (≥ 100 µM) (Rechtman et al., 2010). In the present study, we 
found that curcumin at 10 µM-induced apoptosis of RPE cells (Fig. 8B) while higher 
concentrations induced necrosis of the cells (Fig. 8A, B). The present data confirm data of a 
previous study that showed pro-apoptotic effects of curcumin at 10 µM in RPE cells 
(Alex et al., 2010). Curcumin at 10 µM was also shown to induce apoptosis of retinal 
endothelial cells (Premanand et al., 2006). 
 Curcumin reduces the expression (Fig. 5A) and secretion (Fig. 5B) of VEGF from 
RPE cells. It has been shown in animal models of diabetic retinopathy that dietary curcumin 
inhibits the increase in retinal VEGF (Kowluru and Kanwar, 2007; Mrudula et al., 2007). 
The present data suggest that the downregulation of VEGF is mediated by a direct action of 
 59 
curcumin on retinal cells. Though downregulation of VEGF may have beneficial effects in 
the treatment of diabetic retinopathy and CNV, it may have also detrimental effects. VEGF 
is constitutively released from the RPE under normal conditions; constitutively released 
VEGF is critical in the survival of the choriocapillaris (Blaauwgeers et al., 1999; 
Saint-Geniez et al., 2009). The closure of choriocapillaris endothelial cell fenestrations 
induced by a reduction of the constitutively released VEGF (Blaauwgeers et al., 1999; 
Peters et al., 2007) may contribute to hypoxic conditions in the outer retina which is a key 
feature of AMD (Roth et al., 2004). VEGF constitutively expressed in the retina has 
neurotrophic effects and is required for the survival of photoreceptors and retinal ganglion 
and Müller cells (Gillies, 2006; Saint-Geniez et al., 2008; Brar et al., 2010; Kurihara et al., 
2012; Quaggin, 2012). Long-term treatment of CNV with VEGF antagonists in the clinical 
setting (Campa and Harding, 2011; Chiang and Regillo, 2011) may eventually have 
retinotoxic effects (Gillies, 2006; Brar et al., 2010; Rosenfeld et al., 2011). Significant 
inhibition of the hypoxia-induced secretion of VEGF from RPE cells was found with 
curcumin at 10 µM (Fig. 5B). Because curcumin at this concentration induces delayed 
apoptosis in RPE cells (Fig. 8A, B), the potential harmful effects of the curcumin-induced 
downregulation of VEGF on the choriocapillaris may be associated with a degeneration of 
the RPE. Therefore, systemic long-term administration of curcumin also in other clinical 
settings, e.g., as concomitant cancer therapy, may have detrimental effects on the retina. 
However, this assumption remains to be proved in in-vivo experiments.   
 The pathogenesis of AMD is associated with an apoptotic death of RPE cells, 
followed by photoreceptor cell death (Nowak, 2006). In the present study, we show that 
curcumin decreases dose- and time-dependently the viability of RPE cells via induction of 
early necrosis (at concentrations above 10 µM; Fig. 8A) and delayed apoptosis (at 
concentrations above 1 µM; Fig. 8B). Thus, it can not be ruled out that long-term intake of 
curcumin may facilitate the development of age-related retinal diseases. We found that the 
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cytotoxic effect of curcumin was mediated by various mechanisms including activation of 
caspase-3 and calpain, intracellular calcium signaling, mitochondrial permeability, oxidative 
stress (Figs. 9 and 10), and increased phosphorylation of p38 MAPK and decreased 
phosphorylation of Akt protein (Fig. 11). The partial inhibitory effect of the caspase-3 
inhibitor DEVD on the curcumin-induced DNA fragmentation (Fig. 9) suggests that (in 
addition to caspase-dependent pathways) caspase-independent apoptotic and necrotic 
pathways are involved in the toxic effect of curcumin. The lack of effects of the caspase-8 
inhibitor IETD and the neutralizing anti-TNFα antibody on the curcumin-induced DNA 
fragmentation (Fig. 9) largely rules out the possibility that activation of extrinsic apoptotic 
pathways plays an important role in curcumin-induced cytotoxicity. The present data 
confirm and extent data of a recent study, which showed that curcumin, induces 
caspase-3/7-dependent but caspase-8-independent death and necrosis of RPE cells (Alex et 
al., 2010). The cytotoxic effect of curcumin is also mediated by calpain activation, likely 
due to intracellular calcium overload (Fig. 9). Activation of calpain by calcium is known to 
trigger caspase-dependent and -independent cell death pathways. Mitochondrial apoptosis is 
triggered by intracellular stimuli such as calcium overload and reactive oxygen species 
(Sanvicens et al., 2004; Weber et al., 2005; Li et al., 2009; Galluzzi et al., 2009). We found 
that both mitochondrial permeability transition and oxidative stress are mediators of the 
cytotoxic effect of curcumin (Fig. 9). We found also that curcumin induces activation of p38 
MAPK (Fig. 11A, B) and inhibition of Akt (Fig. 11C). p38 MAPK is generally considered 
to be a proapoptotic MAPK, whereas activation of the phosphatidylinositol-3 kinase-Akt 
signaling pathway was shown to suppress apoptosis and to promote cell survival in various 
different cell systems (Hashimoto et al., 2002; Franke et al., 2003; O'Driscoll et al., 2007) 
including RPE cells (Halapin and Bazan, 2010). Curcumin induced an early downregulation 
and a delayed upregulation of the proapoptotic proteins caspase-3 (Fig. 10A) and Smac (Fig. 
10B). The functional significance of the downregulation of these proteins is unknown. It 
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may be speculated that the curcumin-induced downregulation of proapoptotic proteins may 
inhibit early apoptosis whereas upregulation of caspase-3 (Fig. 10A) and Smac (Fig. 10B) 
after 24 h of stimulation may contribute to the curcumin-induced delayed apoptosis of RPE 
cells observed in the DNA fragmentation experiments (Fig. 8B). We found that generation 
of oxidative stress contributes to the cell viability-reducing effect of curcumin (Fig. 9). 
Excess reactive oxygen species such as hydroxyl radicals and superoxide can cause direct 
damage to lipid membranes, resulting in necrotic cell death. However, further research is 
required to determine the relative contribution of different biochemical cascades leading to 
the curcumin-induced RPE cell death. 
 
4.2. Effects of further bioflavonoids in RPE cells 
 
In the second part of the study, we examined the effects of various other bioflavonoids 
(EGCG, luteolin, apigenin, myricetin, quercetin, and cyanidin) in RPE cells. We found that 
the various flavonoids differentially affect the physiological properties of RPE cells 
including the secretion of VEGF and cellular proliferation and migration, and that some of 
the compounds tested (luteolin, apigenin, myricetin, quercetin) decreased dose-dependently 
the viability of the cells (Fig. 16) and induced apoptosis and/or necrosis (Fig. 18). Overall, 
the effects of the compounds on the physiological parameters were observed at 
concentrations lower than doses that induced a decrease in cell viability. However, the 
concentration windows between the beneficial and detrimental effects depended on the 
compound investigated and were larger in the case of apigenin and smaller in the case of 
myricetin, for example. We assume that the polyphenols tested at low concentrations have 
beneficial effects, as suggested by the VEGF-decreasing effect and the inhibition of cellular 
migration and proliferation, and at higher concentrations, the polyphenols (with the 
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exception of EGCG and cynidin) have toxic effects on the cells. However, further 
experiments are required to support this assumption.  
 EGCG and cyanidin did not significantly affect the viability of RPE cells (Figs. 16A, 
F and 17B) and did not induce apoptosis or necrosis (Fig. 18A, F) at the concentrations 
tested. Cyanidin even reduced the rate of RPE cell necrosis (Fig. 18F). EGCG decreased the 
secretion of VEGF under conditions of chemical hypoxia, but not under control and 
PDGF-stimulated conditions (Fig. 12A). EGCG did not prevent the proliferation and 
migration induced by PDGF (Figs. 14A and 15A). PDGF-induced cellular signaling is a 
major causative factor of proliferative retinopathies (Andrews et al., 1999; Ikuno et al., 
2000). On the other hand, cyanidin inhibited the release of VEGF (Figs. 12F and 17A), the 
proliferation and migration of RPE cells (Figs. 14F and 15F), and the cellular necrosis (Fig. 
18F) without a significant reduction in the cell viability (Figs. 16F and 17B). The data 
suggest that EGCG and in particular cyanidin may have certain benefits to prevent RPE cell 
responses characteristically for AMD.  
 Among the compounds tested, myricetin and quercetin induced strong increases in 
the rate of DNA fragmentation in the culture supernatants at relatively low concentrations 
(Fig. 18D, E). The data obtained with pharmacological inhibitors (Fig. 19A, B) suggest that 
the toxic effect of myricetin in RPE cells (Fig. 16D) was mainly mediated by non-apoptotic 
death modes such as classical and/or programmed necrosis (Morgan and Liu, 2013). There 
are various indications suggesting that activation of apoptotic pathways did not significantly 
contribute to the toxic effect of myricetin in RPE cells: (1) We did not find any 
myricetin-induced increase in the DNA fragmentation rate in the cell lysates (Fig. 18D); (2) 
the caspase-3 inhibitor DEVD did not prevent the myricetin-induced increase in the DNA 
fragmentation rate in the cultured media (Fig. 19A, B); and (3) the inhibitor of the 
mitochondrial permeability transition, cyclosporin A, had no effect on the myricetin-induced 
increase in the DNA fragmentation rate (Fig. 19A, B). The independence of the 
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myricetin-induced cell death from the mitochondrial apoptotic pathway is further suggested 
by the facts that the PARP-1 inhibitor DPQ, the inhibitor of the NADPH oxidase pathway 
and the uncoupling protein-2/mitochondrial pathway, perindopril, and the mitochondrial 
KATP channel opener pinacidil had no effects (Fig. 19A, B). However, the contribution of 
distinct apoptotic pathways, at least of signaling steps upstream from the effector caspase-3, 
can not be fully ruled out because the caspase-8 inhibitor IETD and the JNK inhibitor 
SP600125 decreased the DNA fragmentation rate in the culture supernatants after 6 h of 
stimulation with myricetin (Fig. 19A). Prolonged activation of the stress-activated JNK was 
shown to be an important factor in apoptotic and necrotic cell death (Morgan and Liu, 
2013).  
 We found that the toxic effect of myricetin was mediated by induction of oxidative 
stress and activation of calpains and phospholipase A2 (Fig. 19A, B). Reactive oxygen 
species are known to induce apoptosis and necrosis (Morgan and Liu, 2013). They may 
contribute to JNK activation (Morgan and Liu, 2013), which stimulates the mitochondrial 
production of superoxide (Chambers et al., 2011), a main source of cellular oxidative stress 
involved in the induction of necrosis (Morgan and Liu, 2013). Increased levels of reactive 
oxygen species activate calpains likely by increasing the intracellular free calcium level 
(Sanvicens et al., 2004; Weber et al., 2005; Li et al., 2009). Sustained activation of calpain 
is known to trigger various intracellular signaling processes that lead to progressive plasma 
membrane damage, a hallmark of necrosis (Liu et al., 2003; Harwood et al., 2005). 
Activated calpains may also induce lysosome destabilization (Harwood et al., 2005), at least 
in part by inducing mitochondrial permeability transition (Yang et al., 2012). However, 
because the inhibitor of mitochondrial permeability transition, cyclosporin A, did not 
prevent the myricetin-induced RPE cell necrosis (Fig. 19A, B), it seems to be unlikely that 
myricetin induces a rupture of lysosomes in RPE cells via this pathway. There are various 
necrotic pathways, including programmed necrosis, in which caspase-8 and calpains play a 
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role (Linkermann et al., 2012). Caspase-8 is a subunit of the ripoptosome, which is involved 
in the induction of programmed necrosis (Feoktistova et al., 2011; Tenev et al., 2011). We 
found that the inhibitor of programmed necrosis, necrostatin-1, decreased the myricetin- 
(Fig. 20A) and quercetin- (Fig. 20B) induced increase in the DNA fragmentation rate of the 
cultured media. Because necrostatin-1 does not block the "classic" oxidative stress-induced 
necrosis (Degterev et al., 2005), the data may suggest that the cytotoxicity induced by both 
compounds is in part mediated by inducing programmed necrosis. However, the 
contribution of various apoptotic and necrotic pathways to the myricetin-induced RPE cell 
death remains to be more clarified in future experiments.  
 Further mechanisms may contribute to the induction of RPE cell necrosis by 
myricetin. By degradation of the anchorage to the membrane cytoskeleton, activated 
calpains may impair the activity of the Na,K-ATPase (Inserte et al., 2005). It is known that 
the activity of phospholipase A2 is increased in response to oxidative stress, resulting in 
lipid peroxidation and release of arachidonic acid (Balboa and Balsinde, 2006). Arachidonic 
acid is a potent inhibitor of the Na,K-ATPase that leads to intracellular sodium overload, 
influx of water with consecutive cellular swelling, and possibly membrane rupture (Lees, 
1991; Staub et al., 1994).  
 
4.3. Clinical implications 
 
Vegetable polyphenols are suggested to represent promising drugs for the supplemental 
therapy of cancer in particular because of their capability to induce apoptosis in tumor cells 
(Cao and Cao, 1999; Lambert and Elias, 2010). Bioflavonoids may have also benefits in the 
treatment of retinal diseases (Laabich et al., 2007; Costa et al., 2008; Peng et al., 2008; Park 
et al., 2012; Silva et al., 2013). Because low concentrations of dietary flavonoids (lower 
 65 
than 10 µM) did not decrease the viability of the cells (Figs. 7 and 16) and did not induce 
significant apoptosis or necrosis (Figs. 8 and 18), we assume that normal and moderate 
intake of the compounds as natural food will have no deleterious consequences in the RPE, 
and may have even beneficial effects, in particular in the cases of EGCG and cyanidin. 
However, it cannot be ruled out that increased intake of distinct flavonoids, e.g., of 
curcumin and myricetin, as dietary supplement in the (self-)therapy of cancer, for example, 
may have adverse effects on the retina resulting in dysregulation and degeneration of the 
RPE by inducing apoptosis and necrosis, in particular in subjects with decreased levels of 
anti-oxidant enzymes. The cytotoxic effects of curcumin and myricetin found in the present 
study are mediated by pathogenic mechanisms, which play also a role in the development of 
retinal diseases; for example, oxidative stress-induced mitochondrial dysfunction in RPE 
cells is an important pathogenic factor of AMD (Liang and Godley, 2003). In order to avoid 
accelerated development of AMD and other age-related retinal diseases which are 
associated with dysfunction and degeneration of the RPE, the intake of flavonoids at higher 
doses as supplemental cancer therapy, as anti-viral treatment, or in the treatment of retinal 
diseases should be accompanied by careful monitoring of the retinal function. Possible 
beneficial effects of EGCG and cyanidin, which had little effects on the RPE cell viability in 
the concentration range investigated (Fig. 16), in the treatment of retinal diseases should be 
further examined. 
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Age-related macular degeneration (AMD) is the main blinding disease in the elderly in 
industrial countries. The majority (~90%) of patients suffer from the dry form of AMD that 
is characterized by geographic atrophy of the retinal pigment epithelium (RPE) followed by 
a degeneration of the neural retina. RPE cells play crucial roles in protecting the outer retina 
from photooxidative stress, in the digestion of shed photoreceptor outer segments which 
contain oxidized lipids and proteins, and in inhibition of retinal edema and 
neovascularization. Dysfunction and degeneration of the RPE is crucially involved in the 
pathogenesis of AMD. The remaining patients have the wet (exsudative) form of AMD, 
which is characterized by a subfoveal choroidal neovascularization (CNV). New blood 
vessels grow across the Bruch's membrane below the RPE or across the damaged RPE into 
the subretinal space. The newly formed vessels have a dysfunctional blood-retinal barrier; 
the influx of serum results in the development of subretinal edema and a detachment of the 
RPE. Subretinal edema and dysfunction of the RPE cause apoptotic/necrotic degeneration of 
photoreceptors and thus a progressive decrease in visual acuity.  
 
The development of CNV is assumed to be a response to the hypoxia of photoreceptors; 
Hypoxia induces the production and release of angiogenic factors. The most important 
angiogenic factor is the vascular endothelial growth factor (VEGF). RPE and Müller cells 
mainly produce VEGF. Anti-VEGF therapies improve the visual acuity in approximately 
one third of patients with wet AMD. However, more than half of patients do not improve 
visual acuity after anti-VEGF therapy and about 10% of patients do not respond to the 
treatment. Therefore, it is required to develop novel therapeutic strategies, which inhibit 
further angiogenic signaling pathways. 
 
Vegetable polyphenols (plant bioflavonoids) possess a wide range of activities in the 
prevention of common diseases including cancer, inflammation, infections, 
neovascularization, and neurodegenerative diseases. Intake of bioflavonoids as dietary 
supplements or natural food is suggested to be helpful as supplemental therapy of cancer 
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and chronic inflammation. Many dietary flavonoids have anti-inflammatory and anti-oxidant 
properties. For example, catechins of green tea, of which (-)-epigallocatechin-3-gallate 
(EGCG) is the most abundant, can inhibit tumorigenesis and angiogenesis in tumor tissues. 
The natural phenolic compound curcumin (diferuloylmethane), the yellow pigment of 
turmeric and an ingredient in curry powders has been shown to have anti-inflammatory, 
anti-oxidant, and anti-proliferative effects in various cell systems. The mechanisms of the 
protective activities of flavonoids in various diseases are not fully understood. However, it 
has been shown that excess intake of vegetable polyphenols as dietary supplements or 
natural food may have also adverse effects, e.g., by inhibition of prosurvival pathways and 
induction of apoptosis, as shown for curcumin in human retinal endothelial cells.   
 
Elevated oxidative stress contributes to the pathogenesis of AMD. Anti-oxidant nutrients 
were shown to decrease the risk of the development of age-related macular degeneration. It 
has been suggested that anti-oxidative plant bioflavonoids may have therapeutic effects in 
retinal diseases associated with inflammation and neovascularization. However, plant 
flavovoids may have also adverse effects resulting in the induction of apoptosis, Therefore, 
before plant flavonoids are clinically used in the treatment of retinal diseases such as AMD, 
it is required to determine whether these agents also have detrimental effects in RPE cells. 
Therefore, we examined whether various plant flavonoids have toxic effects in cultured 
human RPE cells. In the first part of the study, we examined the effects of curcumin. In the 
second part of the study, we examined the effects of the following flavonoids: EGCG, 
luteolin (from parsley), apigenin (from celery and parsley), myricetin (from black tea, 
grapes, walnuts, etc.), quercetin (from bulbs), and cyanidin (from various plants such as red 
cabbage, blueberries, and strawberries). 
 
We stained the cells with trypan blue and counted the living and dead cells. curcumin 
decreased slightly the number of viable cells at concentrations between 1 and 50 µM. At 
higher concentrations (75 and 100 µM), curcumin strongly decreased the viability of the 
cells; almost no viable cells were found after the treatment of the cultures with curcumin at 
100 µM. Whereas EGCG and cyanidin up to a concentration of 100 µM did not significantly 
decrease the viability of the cells, luteolin, apigenin, myricetin and quercetin induced 
significant decreases in the cell viability at the higher concentrations tested.  
 
By measurement of the internucleosomal DNA fragmentation rate in the cultured media and 
cell lysates, we determined whether the decrease in RPE cell viability induced by various 
flavonoids was mediated by induction of apoptosis and/or necrosis. An increased level of 
BrdU-labeled DNA fragments in the cell-free culture supernatants reflects cellular necrosis, 
while an increased level of BrdU-labeled DNA fragments in the cell lysates reflects 
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apoptosis of the cells.  
 
Various polyphenols tested (curcumin, luteolin) induced both apoptosis and necrosis of RPE 
cells at higher concentrations, while other polyphenols (apigenin, myricetin, quercetin) 
induced cell necrosis but not apoptosis. The only polyphenol that was found to be 
cytoprotective was cyanidin; cyanidin did not induce apoptosis and decreased the rate of cell 
necrosis.  
 
In order to determine the mechanisms of the cytotoxic effect of curcumin and myricetin, we 
tested various inhibitory agents. An inhibitor of the effector caspase-3 reduced in part the 
curcumin-induced cytotoxicity. Because the caspase-3 inhibitor did not completely block 
the curcumin effect, it is likely that caspase-independent apoptotic and necrotic death 
pathways contribute to the cytotoxic effect of the compound. The calpain inhibitor 
PD150606 fully inhibited the curcumin-induced DNA fragmentation. The inhibitory effect 
of the cell-permeable calcium chelator BAPTA-AM supports the assumption that 
intracellular calcium signaling is involved in mediating the cytotoxic effect of curcumin. 
The data suggest that both caspase-dependent and -independent mechanisms mediate 
curcumin-induced RPE cell death. Overproduction of reactive oxygen species was 
associated with activation of the mitochondrial apoptotic pathway. The curcumin-induced 
cytotoxicity was fully prevented in the presence of the cell-permeable dithiol-reducing agent 
dithiothreitol. One consequence of oxidative stress is activation of mitochondrial 
permeability transition that leads to mitochondrial dysfunction, energy failure, and enhanced 
free radical production. To determine whether mitochondrial membrane permeabilization is 
implicated in mediating the cytotoxic effect of curcumin, we tested the inhibitor of 
permeability transition, cyclosporin A. Cyclosporin A inhibited the curcumin-induced 
cytotoxicity. On the other hand, the curcumin-induced cytotoxicity was not mediated by 
activation of extrinsic apoptotic pathways.  
 
Myricetin was found to induce severe necrosis of RPE cells. We found that caspase 
3-independent necrotic death pathways mediate the myricetin-induced cytotoxicity.  An 
important activator of the caspase-independent cell death is the mitochondrial flavoprotein 
apoptosis-induced factor, which mediates chromatin condensation and DNA-fragmentation 
when translocated to the nucleus. The release of the apoptosis-induced factor from the 
mitochondria can be triggered by different mechanisms, including activation of 
poly(ADP-ribose) polymerase-1 (PARP-1). To determine whether activation of this nuclear 
enzyme participates in myricetin-induced RPE cell death, we used the selective PARP-1 
inhibitor DPQ. DPQ did not prevent RPE cell necrosis induced by myricetin. Similarly, the 
inhibitor of the NADPH oxidase pathway and the uncoupling protein-2/mitochondrial 
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pathway, perindopril, and the inhibitor of mitochondrial permeability transition, cyclosporin 
A, had no effects. The data suggest that activation of the mitochondrial apoptotic pathway is 
not involved in mediating the cytotoxic effect of myricetin.  
  
Because VEGF is a key player in choroidal neovascularization, and RPE cells are one 
source of VEGF in the retina, we determined with real-time RT-PCR and ELISA whether 
bioflavonoids regulate the gene expression and secretion of VEGF from RPE cells. 
Curcumin decreased the gene expression of VEGF in RPE cells. Curcumin also inhibited 
dose-dependently the secretion of VEGF from RPE cells which was induced by PDGF (a 
well-known inducer of VEGF production in RPE cells) and chemical hypoxia (CoCl2), 
respectively. EGCG induced a dose-dependent decrease in the secretion of VEGF induced 
by chemical hypoxia but not by PDGF. All other bioflavonoids tested, i.e., luteolin, apigenin, 
myricetin, quercetin, and cyanidin, induced dose-dependent decreases in the secretion of 
VEGF from RPE cells under all conditions tested. It is likely that the toxic effects of the 
compounds at least at higher concentrations (see above) are one reason for the inhibition of 
the secretion of VEGF of RPE cells. 
 
In conclusion, because low concentrations of dietary flavonoids (<10 µM) did not decrease 
the viability of the RPE cells, we assume that normal and moderate intake of the compounds 
as natural food will have no deleterious consequences in the RPE, and may have even 
beneficial effects, in particular in the cases of EGCG and cyanidin. However, it cannot be 
ruled out that increased intake of distinct flavonoids, e.g., of curcumin and myricetin, may 
have adverse effects on the retina resulting in dysregulation and degeneration of the RPE by 
inducing apoptosis and necrosis. The cytotoxic effects of curcumin and myricetin found in 
the present study are mediated by pathogenic mechanisms, which play also a role in the 
development of retinal diseases. In order to avoid accelerated development of AMD and 
other age-related retinal diseases that are associated with dysfunction and degeneration of 
the RPE, the intake of flavonoids at higher doses should be accompanied by careful 
monitoring of the retinal function. Possible beneficial effects of EGCG and cyanidin in the 
treatment of retinal diseases should be further examined. 
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